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Abstract 
 
 Capillary electrophoresis (CE) separations for the analysis of the chemically-
complex environment of the nervous system have been demonstrated to be an effective 
tool in neuroscience.  The inherent scaling laws of CE allow for the analysis of low-
volume samples at high separation efficiencies which provide a platform for the study of 
neural systems. Here, CE systems using laser-induced, native-fluorescence (LINF) 
detection are described along with its applications for neural analysis across a variety of 
metazoan life.  Selective detection of analytes after separation allows for the expedited 
analysis of complex biological systems by substantially decreasing the electropherogram 
complexity and reducing background interference.  Many tryptophan and tyrosine 
metabolites present in biological systems are amenable to LINF detection.   
 An enhanced wavelength-resolved CE-LINF instrument was developed in an 
effort to take advantage of improvements in technology and electronics to increase 
sensitivity and versatility over prior, similar instruments our lab has developed.  The 
enhanced instrument uses a frequency-doubled, argon-ion laser operating in the deep 
ultraviolet (UV) region (either 264 or 229 nm) for efficient excitation of indolamines and 
catecholamines as well as an UV enhanced charge-coupled device for wavelength-
resolved detection.  Using 264 nm excitation detection limits were 1 nM for serotonin 
and 36 nM for dopamine, approximately 5-fold improvement for both as compared to 
previous systems.  Additionally, the use of 229 nm excitation improved limits of 
detection for tyrosine metabolites by a factor of 2-3 over excitation at 264 nm.  
Our enhanced, wavelength-resolved CE-LINF system has been used to investigate 
a variety of model systems. Using the mouse as a mammalian model, we have 
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demonstrated a significant, non-neuronal source of serotonin to the hippocampus from 
nearby mast cells, a major component of the immune system.  Also, using a genetically 
modified strain of Drosophila melanogaster, we have developed a single-neuron 
sampling method which stabilizes the neuron by adding a temperature-gated arrest of 
neurosecretory activity.  This strain resulted in improved reliability for the detection of 
serotonin in well-characterized neuron as well as the detection of tryptamine which had 
not been previously detected.   Additionally, we have investigated the absence of 
serotonin and many other classical neurotransmitters in the basal phyla Ctenophore which 
compliments genomic studies by our collaborators indicating a lack an enzymatic 
pathway.  While serotonin is an important and well-studied tryptophan metabolite, we 
have begun expanding our system to detect metabolites in the kynurenine pathway. In 
fact, this pathway is responsible for the majority of tryptophan metabolism in mammalian 
physiology and results in the neuroactive compounds kynurenine and kynurenic acid 
which are natively fluorescent.   
 An automated version of a CE-LINF instrument was optimized and evaluated for 
the quantitation of both tryptophan and tyrosine metabolites.  This system uses a metal-
vapor, He-Ag laser with 224 nm output for excitation and a tunable emission detection 
system using a spectrometer and photomultiplier tube, all relatively low-cost components.  
The system demonstrated excellent linearity over several orders of magnitude of 
concentration and intraday precision of 1–11% relative standard deviation.  Limits of 
detection ranged from 4 to 30 nmol/L for serotonin and tyrosine, respectively.  Extracts 
from mammalian brain stem were analyzed for serotonin and tryptophan with an intraday 
precision of less than 10%. 
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Chapter 1 
 
Introduction 
 
1.1 Research Motivation 
The brain is responsible for an astonishingly wide range of activities and 
behaviors from basic, autonomic functions, to our individual personalities.  Its 
complexity, with billions of neurons and trillions of synapses in an ever-changing 
configuration, makes the brain one of the most difficult mysteries to unravel, even within 
simple organisms.  Investigations of the electrical and chemical signaling pathways of the 
nervous system are important for our understanding of both normal functioning and 
pathologic states.  Tissue and cell specific levels of signaling molecules, their rates of 
synthesis, and dietary availability of precursors have been found to influence neural 
functioning and are often correlated with behavior.
1-4
  Complex sample matrices, volume 
and mass limited sampling methods, and dynamic distribution create interesting 
analytical challenges for chemical analysis.  It is therefore critical to develop and further 
refine techniques for the interrogation of the vast number of chemical species involved in 
signaling, maintenance, and development of the central nervous system (CNS). 
The Sweedler research group has a long history of developing instrumentation 
and methods for analyzing the chemical environment of neural systems at increasingly 
higher spatial, chemical, and temporal sensitivities using a variety of technologies.  These 
methods have included microcoil NMR,
5
 techniques for single-neuron analysis,
6-10
 and, 
the focus of this dissertation, capillary electrophoresis (CE) using laser-induced native 
fluorescence detection (LINF).
7, 11-16
  These CE-LINF systems have been used to detect 
and identify new serotonin catabolism pathways,
17-18
 assay single neurons from Aplysia 
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californica,
7
 and measure serotonin from mast cells in the hippocampus.
19
  Progress in 
electronics and technology provides the potential to build updated and enhanced CE-
LINF instrumentation with improved performance including lower detection limits and 
higher throughput.   
The overarching goal of this dissertation has been to create an enhanced capillary 
electrophoresis instrument with wavelength-resolved, laser-induced native fluorescence 
detection and apply it to the investigation of model neural systems.  These investigations 
include the analysis of well-characterized invertebrate neurons, studying the role of mast 
cells in serotonin signaling within the mammalian hippocampus, and unusual tryptophan 
metabolic pathways.  
 
1.2 Thesis Overview 
The remaining portion of Chapter 1 provides short overviews/reviews of the 
major topics presented, ranging from the fundamentals of CE instrumentation, to the 
specific pathways in the nervous system, to the biological models used during our 
investigations of neural systems.  This background allows the specific development 
efforts and investigations to be placed into a broader context.  Chapter 2 describes the 
design, development, and of the characterization of the wavelength-resolved CE-LINF 
instrumentation with 229 and 264 nm excitation wavelengths.  Chapter 3 covers the use 
of native fluorescence detection with an automated capillary electrophoresis system for 
the detection and quantitation of small-molecule metabolites of tryptophan and tyrosine 
in collaboration with Beckman Coulter Inc., and will hopefully result in a commercially 
available instrument that may popularize native fluorescence detection in capillary 
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electrophoresis.  Chapter 4 describes new investigations of a non-neuronal source of 
serotonin in the mammalian brain which appears to contribute significant amounts of 
serotonin to the hippocampus.  Chapter 5 describes a new application of CE-LINF 
instrumentation; more specifically, the quantitation of kynurenine-related metabolites is 
highlighted.  Chapter 6 describes the analysis to determine if serotonin or other classical 
neural signaling molecules are present in the evolutionarily primitive ctenophore, 
Pleurobrachia. This model represents one of the simplest animal groups with a nervous 
system and aids in our understanding of neuronal cell-to-cell signaling through evolution. 
Chapter 7 details the use of genetically modified Drosophila melanogaster with a 
blocked neurosecretory system to interrogate single neurons from the well-characterized 
genetic model.  Each chapter contains a “Future Directions” section that includes 
suggestions for the future of the research and may act as a guide for additional follow-up 
studies. 
 
1.3 Instrumentation 
1.3.1 Capillary Electrophoresis 
Electrophoresis separates charged species based on differential migration rates 
within an electric field. Electrophoretic separations date to the pioneering work of 
Tiselius in the 1930s, for which he was awarded a Nobel Prize in 1948.
20
  In 1981 
Jorgenson and Lukacs reported an electrophoretic separation technique within open, 
fused-silica capillaries rather than the typical application of electrophoresis to protein 
separation within gel slabs; a remarkable aspect of their work was the outstanding 
separation efficiency and fast separation times.
21-24
  The invention and development of 
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the open-tublar, fused-silica capillary made robust and flexible by external coatings has 
led to improved separations in gas chromatography, capillary liquid chromatography, and 
the development of practical CE systems over the past three decades.  Separation 
efficiencies in CE are directly proportional to the applied voltage (typically 20-30 kV), 
equation 1.1 where µ is the mobility of a species in an electric field, V is the applied 
voltage, and D is the diffusion coefficient. 
   
  
  
 Equation 1.1 
The flow profile in CE is plug-like rather than parabolic as in traditional chromatography 
which uses pressure-driven flow.  This profile substantially reduces peak broadening and 
is one of the major reasons separation efficiencies can exceed 10
6
 theoretical plates.  On-
line sample concentration techniques are another advantage in CE by improving the 
already impressive separation efficiencies by decreasing the length of analyte bands 
within the capillary.
25
  One technique, field-amplified stacking, occurs when the injected 
sample is less conductive than the background electrolyte, creating high, local electric 
fields concentrating the charged analytes into narrow bands at the boundaries of the 
injected sample plug.
26
  This allows for relatively large sample volumes (increased 
analyte abundance) to be injected while maintaining the high resolution with narrow 
analyte bands.  The methods described throughout this work take advantage of field-
amplified stacking to improve detection limits and increase separation efficiencies.  
The application of CE separations to neuroscience has been particularly useful 
due to the inherently high separation efficiencies and low-volume sample requirements 
which have been recently reviewed by Lapainis et al.
27-28
  With sampling techniques 
requiring volumes in the nanoliter regime, varying levels of cellular and chemical 
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organization can be investigated within the CNS, ranging from entire brain regions, to 
single cells, and even to subcellular organelles.   
A number of different detection methods can be coupled to CE separations for 
analysis — electrochemical (EC),29 UV absorbance,23 laser-induced fluorescence 
(LIF),
30-31
 and mass spectrometry
32
 depending on the specific question to be investigated 
and the chemical species of interest.  The majority of the work reported within this 
dissertation concerns LINF; this detection mode is discussed in the next section of this 
chapter.    
 
1.3.2 Native Fluorescence Detection 
A subset of biomolecules derived from the aromatic amino acids tryptophan and 
tyrosine exhibit intrinsic fluorescence upon excitation in the deep UV (200-300 nm), 
accessing S0  S1 or S0  S2 transitions.
33
  Tryptophan, tyrosine, their metabolites, and 
the peptides and proteins containing these residues have fluorescence quantum yields 
ranging from 0.13 - 0.28.
34-35
 The typical fluorescence emission for these species is in the 
range of 300-500 nm.  With both excitation and emission wavelengths primarily in the 
UV, significant constraints are placed on excitation and detection equipment and is the 
topic for the remainder of this section.  For most recent review of the state of the art of 
LINF techniques see  Gooijer et al.
36
 
Early CE-LINF instrumentation used a frequency-doubled, argon-ion laser as the 
excitation source (257, 305, 275 nm).
11, 37-38
  Currently, the major detraction of LINF as a 
more common detection method is the limited availability and high price of deep UV 
excitation sources that are both space and economically efficient.  Traditionally, these 
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have been limited to large-frame, frequency-doubled, gas-ion lasers and frequency-
quadrupled Nd:YAG lasers; both are large, high-cost lasers.  In recent years, the 
advancements in light emitting diode (LED) technology to access higher energy 
wavelengths make them a viable deep UV excitation source.
39
  With relatively low 
purchase and operating costs, LEDs are poised to develop cost-effective instrumentation 
that could make the technique more widely accessible.  In addition to LEDs, hollow-
cathode, metal-vapor lasers have been used in several LINF detection systems which 
access wavelengths in the deep UV affordably.  Currently, the two reported 
configurations for these lasers are He-Ag
16
 and Ne-Cu
40
 with outputs at 224.3 and 248.6 
nm respectively.  Both configurations have excellent power and beam profiles for LINF 
applications, but are pulsed with durations of hundreds of microseconds and a typical 
maximum repetition rate of 5 Hz.  These lasers have been effective, but higher duty 
cycles would improve their performance. 
While many instruments have been designed with single-channel detection, LINF 
can be used as an information-rich method when using multichannel detection schemes.  
The use of spectral information for the identification of analytes based on fluorescence 
emission in addition to migration time increases the confidence of peak assignments.  
The earliest report of multichannel detection used in CE was by Kobayashi et al. using a 
photodiode array
41
 and was shortly followed by the development of instruments using 
charge coupled devices (CCDs).
42-43
  Multichannel detection has been used for DNA 
sequencing,
44
 single-neuron analysis,
7
 environmental monitoring,
45
 and discovery of new 
serotonin metabolites,
46
 demonstrating the value and versatility of the detection method 
7 
 
even though it only accesses a small subset of molecules that are fluorescent using deep 
UV excitation. 
 
1.4 Tryptophan Metabolism in Neural Systems 
Early life used the indole ring of tryptophan to capture photons during the 
photosynthesis process.
47
  While tryptophan is routinely synthesized in plants, animals 
must consume it in their diet, resulting in a limited supply.  This limited source has likely 
led to it being highly regulated throughout animal physiology.  In addition to its use in 
protein and peptide synthesis, a number of major neurotransmitters and neuromodulators 
are derived from tryptophan metabolism.  The three major metabolic pathways of 
tryptophan are outlined in Fig. 1-1: serotonin, kynurenine, and tryptamine.  
The metabolism of tryptophan into serotonin is a well-conserved pathway 
originating in unicellular organisms around 3 billion years ago.
48
  Interestingly, serotonin 
is present at higher levels in plants than animals.
49
  The early appearance of serotonin in 
the evolution of life has led to its incorporation into many critical processes.  Since the 
identification of serotonin in 1952 it has become the target of extensive study and a 
multi-billion dollar pharmaceutical target.
50
  Although serotonin is well-known for its 
role in the CNS, its original isolation was from enterochromaffin cells in the enteric 
nervous system where it is responsible for smooth muscle contractions.
51
 In fact, 
serotonin plays a large role in the enteric nervous system which contains an estimated 
95% of the human bodies total serotonin content with only ~5% present in CNS.
52
  
Serotonin signaling is critical to homeostasis, acting as both a neurotransmitter and 
trophic factor.  Serotonin signaling regulates neurogenesis,
53-54
 mood,
55
 body 
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temperature,
56
 appetite,
3
 memory, and learning.
57
  Metabolism of serotonin into 
melatonin within the pituitary is implicated in regulating circadian rhythm.  Disruption of 
serotonin signaling results in numerous disease states.
4
  Dysfunction of serotonin 
signaling is involved in depression,
58
 anxiety,
59
 and many neurodegenerative diseases.
60-
61
  With such critical and diverse roles it is important to continue investigating the 
serotonergic system in the CNS as well as other tryptophan metabolites. 
 Although serotonin is the most well studied tryptophan metabolite it represents 
only a small fraction of all tryptophan metabolism, more than 90% of tryptophan goes 
through the kynurenine pathway (KP).  The metabolism of tryptophan into the KP within 
the brain begins with tryptophan 2,3-dioxygenase (TDO) in the liver or indoleamine 2,3-
dioxygenase (IDO) in rest of the body.
62-64
  Pro-inflammatory cytokines can regulate this 
pathway by inducing or suppressing expression of IDO.
65
  As these cytokines are 
regulated by the immune system signaling, IDO expression is largely controlled by the 
immune system, creating a link between the biochemical content of the brain and the 
activity of the immune system.
66-67
  The downstream metabolites in the KP include the 
neuroactive compounds kynurenine, kynurenic acid, and quinolicic acid.  These 
metabolites have both neuroprotective and neurotoxic actions on neurons.
63
  Kynurenic 
acid demonstrates neuroprotective properties and is produced from kynurenine by the 
enzyme kynurenine aminotransferase (KAT) preferentially localized in glial cells.
68
  
Quinolinic acid is an NMDA receptor agonist and can be toxic to neurons.  The 
relationship between specific KP metabolites of the CNS are reviewed by Stone.
69
  KP 
metabolite levels are linked to diseases including Huntington’s, Alzheimer’s, and 
multiple sclerosis as well as chronic infections such as Lyme disease, malaria, and AIDS.  
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The impact of KP metabolites on the CNS has created interest in developing 
pharmaceutical-based therapies creating a demand for measure techniques for these 
metabolites.
69-71
 
 
1.5 Biological Models 
The Sweedler group uses a reductionist approach in the investigation of neural 
systems by employing several model systems, each with attributes amenable to the 
particular study.  For example, Aplysia californica are commonly used because of a 
relatively simple nervous system (~10,000 CNS neurons) which is physiologically well 
defined with large, individual neurons — making it an excellent model for method and 
instrument development.
72
  Investigations included in this dissertation have used mice, 
ctenophores, and drosophila as model species; their general characteristics and specific 
genetic variants are discussed below.  
 
1.5.1 Mouse 
The mouse is a classic model system for mammalian biology and is often used as 
a corollary for human physiology.
73
  Genetic manipulation creating both transgenic and 
knockout strains allow for investigations of specific genes, and in some cases replication 
of human diseases.  Chapter 4 uses a strain, C57BL/6-Kit
W-sh/W-sh
(W
sh
/ W
sh
), devoid of 
mast cells due to a naturally occurring mutation in the white spotting locus, suppressing 
the c-kit receptor expression preventing differentiation of mast cells from their progenitor 
cells.
74
  This strain of mouse has been used extensively as a method to study mast cell 
biology in vivo.
75
  Interestingly, mast cells are known to cross the blood-brain barrier and  
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mature in areas of the brain for several mammalian species including the rat, mouse, 
dove, vole, and human, but their exact function in the CNS has undergone limited 
investigation.
76-79
 Behavioral studies show increased levels of anxiety and profound 
deficits in hippocampal learning and spatial memory in this mast cell deficient strain.
19, 80
   
 
1.5.2 Drosophila 
The genome of drosophila was one of the first sequenced and with little genetic 
redundancy specific genes can be linked to behavior and biochemical production.
81-82
  
Neurotransmitters have been linked to specific behaviors and functions such as 
octopamine in aggression,
83
 dopamine in both arousal
84
 and olfactory memories,
85
 and 
tyramine for addiction to cocaine.
86
  Numerous techniques have been developed for the 
genetic manipulation of drosophila, and combined with their short reproduction cycle, 
allows for the breeding of genetic variants quickly and at low cost, particularly using the 
UAS/Gal4 system.
87
  One difficulty in the analysis of the drosophila nervous system is its 
small size.  The total brain is only ~5 nL in volume and individual neurons are between 
5-10 µm in diameter.  The genetic models used in the work described in chapter 7 
contained two genetic variants within the same fly to assist in single-cell analysis - GFP 
co-expressed with tryptophan hydroxylase, the rate limiting enzyme for serotonin 
production,
88
 and a Shibire mutant which reversibly blocks the neurosecretory system 
above a threshold temperature of 30°C. Under a fluorescence microscope the cells 
expressing tryptophan hydroxylase are easily visualized allowing for dissection of 
serotonergic cells while the blocked neurosecretory activity prevents inadvertent release 
of contents during the dissection process.   
11 
 
1.5.3 Ctenophore 
The complex nervous systems present in higher order animals have their origins 
in the earliest metazoan life.
89
  The use of molecular genomic techniques has revealed 
many new relationships among Bilateria,
90
 but there is poor resolution of placement 
among early phyla.
91-92
  One method in understanding the conservation of signaling 
pathways is to study the ancient systems of early species such as the Ctenophore, 
Pleurobrachia.  Ctenophores diverged prior to the occurrence of Bilateria but still have a 
differentiated, yet diffuse, nervous system with synapses that are bidirectional.  This 
rudimentary nervous system is not centralized and is often described as a neural net.
93
  
However, even without the advanced organization seen in higher species it can still feed, 
reproduce, and defend itself.   
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1.6 Figure
Kynurenine Metabolites 
• Inflammatory regulated pathway 
• Downstream metabolites are both 
neuroprotective and neurotoxic 
• Implicated in numerous 
neurodegenerative disease 
• Alzheimer's 
• Parkinson's 
• Multiple sclerosis 
• Huntington's 
Serotonin Metabolites 
• Homeostasis 
• Temperature regulation 
• Neurogenesis 
• Digestion 
• Circadian rhythm 
• Pathologies  
• Depression 
• Schizophrenia 
• Irritable bowel syndrome 
Fig. 1-1 Shown here are the major, neuroactive 
metabolites of tryptophan. 
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 Chapter 2 
 
Improved Capillary Electrophoresis Instrumentation Using 
Wavelength-Resolved, Laser-Induced Native Fluorescence Detection 
 
Notes and Acknowledgements 
  We would like to acknowledge the skills and assistance of the School of 
Chemical Sciences Machine Shop in manufacturing and modifying equipment during the 
design and construction of the instrumentation described within this chapter.  Funding for 
a new laser excitation source was secured by a supplement to the National Institute of 
Neurological Disease and Stroke’s grant NS031609, with the rest of the equipment 
coming from both NS031609 and DE018866.  This work builds on and updates the prior 
CE-LINF systems created and used by Dr. Aaron Timperman, Dr. Kurt Oldenburg, Dr. 
Robert Fuller, Dr. Jeffrey Stuart, Dr. Xin Zhang and Dr. Leah Squires as cited herein.  
 
2.1 Introduction 
The chemical analysis of neural systems oftentimes requires highly sensitive 
bioanalytical techniques compatible with volume- and mass-limited sampling methods to 
investigate the chemical content of the billions of neurons and trillion of synapses within 
the brain.  With the complex cellular organization of neural systems, analysis at vastly 
varying levels from whole brain, to individual regions and structures, to single neurons, 
and even subcellular domains provides valuable information about chemical 
distribution.
1-3
 
While there are many metabolic pathways integral to the central nervous system 
(CNS), those related to indoles and catechols are highlighted here.  Tryptophan and 
22 
 
tyrosine metabolism produces neurotransmitters, trophic factors, enzyme cofactors, and 
neuromodulators critical to the functioning of neural systems that are related to functions 
and behaviors including aggression,
4
 anxiety,
5
 depression,
6-7
 and feeding
8
 as well as 
numerous pathologies.  Even though many of these neuroactive compounds have been 
well researched, the underlying mechanisms are still not well understood, particularly in 
complex interactions between pathways.  As an example, reward and addiction pathways 
are known to be dopaminergic,
9-10
 but serotonin signaling has been shown to be 
inhibitory to dopaminergic systems within the brain as reviewed by Daw et al., 
complicating model addiction paradigms.
11
 Investigations into the function of these 
compounds will be aided by both the development of new and the improvement of 
existing selective, sensitive, and quantitative methods, particularly systems capable of 
multi-analyte analysis.  
Capillary electrophoresis (CE) has been an effective tool in neuroscience 
investigations as reviewed by Lapainis et al.
12
 and Powell et al.
13
  High separation 
efficiencies, on-line sample concentration, and, most importantly, low sample volume 
requirements make CE well-suited for the analysis of highly complex, mass- and volume-
limited samples.  These attributes enable analysis at high spatial resolution, down to the 
single neuron and subcellular levels.  Additionally, compatibility of CE with a variety of 
detection methods allows for the analysis of analytes with a wide range of 
physiochemical properties.  Common methods include electrochemical,
14
 UV 
absorption,
15
 mass spectrometry,
16
 conductance,
17-18
 and fluorescence
19
 detection 
schemes.  Applications in neuroscience have relied primarily on electrochemical and 
fluorescence systems given their high sensitivities. 
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Fluorescence has been an attractive detection method for CE since its original 
description by Jorgenson and Lukacs in 1981 which used a mercury arc lamp for 
excitation.
20
  The advent of lasers as an excitation source have made fluorescence even 
more applicable and competitive among the available detection schemes.
21
  Fluorescence 
can be achieved either by derivatization of target molecules with a fluorophore or by 
taking advantage of the intrinsic fluorescence exhibited by a subset of molecules.  
Numerous derivatization reactions for fluorophore addition to analytes prior to detection 
have been developed and have often yielded exceedingly low levels of sensitivity,
22-23
 but 
these reactions are often complex, incomplete, unstable, or non-specific, drawbacks that 
are particularly problematic with samples of limited volume.
24-26
  Taking advantage of 
the intrinsic fluorescence of analytes for unlabeled detection avoids the pre-analysis 
reactions and reduces interfering signals from co-migrating peaks.  Biological systems 
contain a number of natively fluorescent compounds.  The amino acids tryptophan and 
tyrosine have absorbance cross sections and sufficient fluorescence quantum yields that 
allow for detection by native fluorescence at trace levels.
27-28
  As a result, many 
metabolites of tryptophan and tyrosine along with peptides and proteins containing these 
residues have excitation and emission spectra in the deep UV, 200-300 nm and 300-400 
nm respectively.  The early work developing CE-LINF used the 275.4 nm line from an 
argon-ion laser to excite tryptophan and tyrosine containing peptides
29
 with later 
applications targeting small-molecule metabolites.
30-33
  Native fluorescence has also been 
used to visualize dynamic serotonin release from living cells.
34
 
Wavelength-resolved fluorescence detection in CE is an effective, information-
rich method for identification and quantitation of fluorescent analytes when combined 
24 
 
with LINF excitation.  Since the initial description of wavelength-resolved detection 
systems for CE using a photodiode array
35
 and later using an optimized CCD system,
36
 
several systems have been developed for a wide range of applications including 
quantitative analysis of peptides
37
 and proteins,
38
 characterization of protein folding,
39
 
analysis of environmental contaminants,
40
 DNA sequencing,
41
 and neurotransmitter 
analysis.
42-44
  These instruments have used photodiode arrays, multiple PMTs,
45
 and 
charge-coupled devices (CCD)
46
 as high information, multichannel detection systems.  
Our group has constructed several versions of CE-LINF instruments, some equipped with 
wavelength-resolved detection.
45-51
  These systems have been used to detect and identify 
new serotonin catabolism pathways,
42, 44
 assay single neurons from Aplysia californica,
49
 
and measure serotonin from mast cells in the hippocampus.
52
 
The instrumentation described here is an update and redesign to our previous 
systems intended to improve performance, versatility, and throughput.  With this 
redesign, the sensitivity was improved for the tested analytes primarily due to a UV-
enhanced CCD that is well-suited measuring fluorescence from 250-700 nm with 
quantum efficiencies (QE) of 60-70% in the 300-400 nm range.  Additionally, multiple 
readout rates and gain settings for the CCD allow for optimization for analysis at high 
sensitivities or quantitation of intense signals.  Longer exposure times are possible given 
the increase in readout speed, improving signal-to-noise ratios.  The control software was 
designed for spectroscopic measurements and substantially improves practical use and 
throughput.  An argon-ion laser operating in the deep UV was used with flexibility of 
excitation at either 264 or 229 nm. Improvements in detection limits were approximately 
5-fold for serotonin and dopamine and 2-3 fold for epinephrine and octopamine.  With 
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sensitivities competitive with the current state of the art and the additional information-
rich, wavelength-resolved detection, the system is capable of providing sophisticated 
analyses from a range of neural systems. 
 
2.2 Experimental 
2.2.1 Chemicals and Solutions 
Standards and chemicals were obtained from Sigma-Aldrich (St. Louis, MO, 
USA) at the highest purity possible unless otherwise noted. Serotonin was purchased 
from Alfa Aeser (Ward Hill, MA, USA).  Water for solutions and standards was obtained 
from an Elga PureLab Prima water filtration system (Woodridge, IL, USA) at purity of 
18.2 MΩ.  
Extraction media consisted of 49.5/49.5/1, methanol (LC-MS grade)/water/glacial 
acetic acid (99%) by volume.  Standards were weighed (1-2 mg) on a microbalance 
(Mettler Toledo; Columbus, OH, USA) and dissolved in extraction matrix for high 
concentration stock solutions.  These stocks were stored at -80°C until use when diluted 
to working concentrations. Citric acid (25 mM, pH 2.5) used for sheath-flow liquid was 
prepared by dissolving 5.25 g citric acid in 1.0 L ultrapure water.    Borate buffer (50 
mM, pH 9.25) for separations was prepared by dissolving 9.2 g of sodium borate with 3.0 
grams of boric acid in 1 L of ultrapure water.  Both the citric acid and borate buffers were 
filtered using a 0.22 µm vacuum filter and degassed by maintaining the vacuum for 20 
minutes while stirring.  
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2.2.2 Instrument Design 
The major design considerations for the instrument were excitation source, 
separation and detection interface, and fluorescence detection.  A diagram along with 
photographs of the primary components of the laboratory-built CE-LINF instrument are 
presented in Fig. 2-1.  The excitation source was an Innova 90c argon-ion, frequency-
doubled (FreD) laser (Coherent, Inc.; Santa Clara, CA, USA).  Accessible deep UV 
wavelengths were 229 and 264 nm by use of 2 different beta barium borate (BBO), 
frequency-doubling crystals.  Excitation occurs post-capillary within a 3x3x45 mm UV-
grade, fused-silica cuvette which was open at both top and bottom (Starna Cells, Inc.; 
Atascadero, CA, USA).  The laser was focused approximately 1.0 mm below the outlet 
of the capillary.  Fluorescence was collected orthogonal to the excitation path using a 
MgF2 coated all-reflective collection objective (12596; Newport; Irvine, CA, USA).  The 
collected fluorescence emission was imaged onto the CCD array by a flat-field corrected 
grating (CP140-103; Horiba Scientific; Edison, NJ, USA).  The CCD detector (Spec-10; 
2KBUV/LN; Princeton Instruments; Trenton, NJ, USA) was back-illuminated with an 
antireflection UV coating, yielding quantum efficiencies of 60-70% in the deep-UV 
(300-400 nm).  The active area of the array is 512x2048 pixels with each measuring 13.5 
x 13.5 µm.  The CCD is equipped with a dual-speed digitizer (100 kHz and 1 MHz) as 
well as low-noise and high-capacity output modes which allowed the system to be 
versatile for trace detection or quantitation of intense signals.  The spectral range 
recorded was 275 – 700 nm. 
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2.2.3 Instrument Control and Data Processing  
Individual fluorescence spectra were obtained by binning every 2 columns on-chip 
producing a spectrum of 1024 data points for each exposure.  The exposure of the CCD 
array started with a +5 volt TTL pulse and lasted for as long was set within the CCD 
control software.  Typically, data was collected at 2 Hz with 440 ms of active collection, 
50 ms to read the data from the array, and a 10 ms gap before the arrival of the next TTL 
pulse.  The TTL pulses were generated using computer controlled, USB digital I/O 
device from National Instruments (Austin, TX, USA) with the frequency and duration of 
pulses controlled by a laboratory-written LabView (National Instruments; Austin, TX, 
USA) program.  Emission spectrum from a Hg(Ar) pen lamp (Oriel Instruments; 
Stratford, CT, USA) was used for wavelength calibration of the CCD. 
The raw data was imported into MatLab (The MathWorks Inc.; Natic, MA, USA) 
for processing, smoothing, visualization, and quantitation. The background was 
subtracted by averaging the first 50 fluorescence spectra, prior to analyte elution from the 
capillary, and subtracted from each individual spectrum within the data matrix.  The 
active array of the CCD is sensitive to charged particles generated from the impact of 
cosmic rays with gaseous nuclei in the upper atmosphere.  These secondary cosmic rays 
degrade into mostly muons which pass through the active area on the CCD array and 
result in signal spikes. These are identified by the relatively narrow peak characteristics 
both in the time and fluorescence domains of the data.  The spikes are less than 3 adjacent 
pixels in width and are confined to an individual exposure making them readily 
identifiable in comparison to typical, broader features produced by analytes in the 
electropherogram. 
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The most significant sources of high-frequency noise present within the system are 
from optical shot noise and electronic noise from the CCD system hardware and signal 
transduction.  Several smoothing methods were evaluated – boxcar averaging, Savitzky–
Golay, and a two-dimensional Gaussian filter.  The filtering method that produced the 
best signal-to-noise ratio was a two-dimensional Gaussian filter optimized for both 
wavelength and time domains.
47
  Size and power of the filter was optimized based on a 
collection rate of 2 Hz and the fluorescence spectra obtained from multi-analyte standard. 
 
2.2.4 Electrophoresis 
A 50/150 µm ID/OD fused silica capillary (Polymicro Technologies; Phoenix, 
AZ, USA) was used as the separation column.  Capillaries were conditioned prior to use 
by flushing with 0.1 N sodium hydroxide for 5 minutes and then flushed with separation 
buffer for a minimum of 5 min.  Sample injections were hydrodynamic by lowering the 
waste outlet and siphoning 10 nL of sample into the capillary from the custom, stainless 
steel nanovials.  Separations were performed using 25 mM citric acid for dopamine, 
epinephrine, and norepinephrine and 50 mM borate separation buffer for all other 
compounds.  25 mM citric acid was used as the sheath-flow liquid for all separations.  
Voltage was applied using a variable, up to +30 kV, high voltage power supply 
(Spellman; Hauppauge, NT, USA) in conjunction with a laboratory-built control box.  
Applied voltages were +21 kV for separations using 50 mM borate as the separation 
buffer and +30 kV for those using 25 mM citric acid. 
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2.2.5 Data Analysis 
Limits of detection were defined to be the concentration of analyte that produces a 
signal-to-noise ratio of 3 with the signal being the peak fluorescence intensity and the 
noise being the standard deviation of the background directly preceding the peak.  Each 
analyte was analyzed individually at a concentration of 2 µM and the data processed as 
described in section 2.2.3 “Instrument Control and Data Processing”.   
 
2.3 Tissue Extraction 
Brain stem tissues were dissected from Sprague Dawley rats purchased from 
Harlan, Inc. (Indianapolis, IN, USA).    Animal euthanasia was performed in accordance 
with an animal use protocol approved by the University of Illinois’ Institutional animal 
care and use committee, local, and federal regulations.  Brainstem was surgically 
removed immediate after animal decapitation by sharp guillotine.  The excised brain 
structures were flash frozen in dry ice cooled isopentane and transferred into individual 
capped plastic tubes and stored at -80°C until extraction.  Extraction media was added to 
the weighed tissue at a ratio of 5 µL/mg of wet weight tissue.  The tissue was manually 
homogenized with the extraction media and allowed to extract at for 90 min, centrifuged 
at 16,000 g for 15 min, and then the supernatant was filtered using an Amicon 10 kDa 
MWCO filter (Millipore; Billerica, MA, USA) at 4°C and stored at -80°C until analysis. 
 
2.4 Results and Discussion 
Wavelength-resolved detection when using native fluorescence provides an 
information-rich detection method where analytes can be interrogated not only by 
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migration time, but spectral characteristics as well.  Our goal here was to build an 
updated and improved instrument based on our previous successes using CE-LINF 
methods over the previous 15 years.  Improvements in technology allows for a more 
sensitive, efficient, and versatile instrument to be built for the analysis of tyrosine and 
tryptophan metabolites within neural systems, as well as correct for issues related to 
failing components in the original system.   
 
2.4.1 Instrument Design 
The instrument setup along with photographs of the key components and 
interfaces are given in Fig. 2-1.  There were two major design considerations - excitation 
source and detection system. Excitation sources in the deep UV have traditionally been 
gas-ion lasers or frequency-quadrupled Nd:YAG lasers, but more recently laser emitting 
diodes (LEDs),
53
 diode-pumped, solid-state lasers,
54
 and hollow-cathode, metal-vapor 
lasers
45, 50
 have been developed which access wavelengths in the deep UV and have been 
used as excitation sources for LINF instrumentation.  Here, an argon-ion laser was 
selected for its stability and access to several different wavelengths in the DUV, 
specifically 229 and 264 nm for this system using two different beta barium borate 
crystals.  Indoles are efficiently excited at 264 nm, however, catecholamines have a 
larger absorbance cross section at 229 nm which accesses the S0-S2 transition.
55
  The 229 
nm option of the instrument is accessible, but the available output power is much lower 
than 264 nm, ~0.5 mW and 15 mW respectively.  
As the fluorescence emission for the analytes of interest is in the 300-500 nm 
range, a specialized UV sensitive CCD is required.  Typical CCD arrays are not 
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responsive to photons in the UV region, but detection can be accomplished using a 
phosphorus coating to red shift incident photons to a wavelength where the CCD has a 
higher quantum efficiency
56-57
 or by design changes for thinned, back-illuminated 
devices with anti-reflection coatings which increase the quantum efficiency in the UV.
58
  
The back-illuminated CCD array used here was designed to enhance the quantum yield in 
the UV region using anti-reflection coatings instead of the photon conversion as has been 
used on our previous instruments.  The result is an impressive quantum yield of 60-70% 
in the 300-400 nm range.  Readout rates for this CCD are also substantially improved and 
variable to facilitate either low noise or fast acquisition by built-in, dual-speed digitizers. 
With LODs and separation efficiencies significantly affected by signal processing, 
several methods were evaluated to remove high-frequency noise.  Parameters were 
optimized for box car averaging, Savitzky-Golay, and Gaussian filtering.  The 
application of a Gaussian filter improved the signal-to-noise ratio while still retaining 
peak height and width resulting in the lowest LODs.  This filter was two-dimensional and 
both the wavelength and time domains were optimized for the typical feature size for 
each.  Application of this filter resulted in a 5-10 fold decrease in LODs for most analytes 
over unprocessed data. 
 
2.4.2 Performance 
One of the goals of building this instrumentation was to improve upon our 
previous instruments sensitivities for a wide range of analytes by using a more efficient 
CCD and access to excitation wavelengths optimal for two classes of compounds – 
indoleamines (264 nm) and catacholamines (229 nm).  With the gain, exposure, and 
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readout set for high sensitivity, excellent LODs at both 229 and 264 nm were obtained. A 
summary of LODs are provided in Table 2-1 along with reported detection limits from 
our previous instrument.
59
  LODs were improved for all tested analytes.  Significantly, an 
improvement from 5 nM to 1 nM for serotonin and 120 to 23 nM for dopamine.  
Dopamine, epinephrine, and norepinephrine were separated in 25 mM citric acid rather 
than the 50 mM borate buffer used for the other analytes as the fluorescence signal is 
significantly better, likely due to the complexation of borate with compounds like 
dopamine.  Even though parameters were optimized for sensitivity, the dynamic range 
exceeded a minimum of 2 orders of magnitude (10-1000 nM).  Here, sample injection 
was accomplished using hydrodynamic injection rather than the previously used 
electrokinetic method.  It is important to note that the reported detection limits in Table 
2-1 are routinely achieved without extraordinary alignment or preparation procedures; in 
the past, the instrument had to be optimized daily to achieve the reported LODs and so 
another major enhancement is the robust operation of the system. 
The performance here is comparative to other recent methods for neurotransmitter 
analysis as reviewed by Perry et al.
60
  Within CE separations laser-induced fluorescence 
and electrochemical detection have typically been demonstrated to be the most sensitive.  
For example, Benturquia et al. describes a CE-LINF instrument using a single-channel 
detector and a pH-mediated, on-column concentration technique that achieves an 
impressive 0.25 nM detection limit for serotonin.
54
  While indoleamines such as 
serotonin are highly fluorescent, catecholamines are less fluorescent, but have a stronger 
electroactive response and a number of CE-EC methods have been developed for 
detection in the low nM regime.
60
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The instrument described here can be used to identify analytes based on spectral 
characteristics as well as migration times as demonstrated in Fig. 2-2.  This information 
is particular useful for analytes that have similar migration times for a particular 
separation method.  Often times, in preparations of samples derived from biological 
sources the matrix contains salts which change the local electric conditions, as well as 
proteins and peptides that can coat the capillary walls, both significantly alter migration 
times making peak identification difficult.  Identification based on spectral 
characterization significantly improves the ability to identify peaks even with the 
degraded migration reproducibility from biological sample matrices.  Baseline resolution 
and quantitation can be achieved for co-migrating analytes by using specific wavelengths 
for analysis of compounds with differing fluorescence spectra. 
 Applications to the analysis of biological extracts from neural tissues was 
demonstrated using the brainstem of a rat.  Analysis at both 264 and 229 nm under the 
same separation conditions, Fig. 2-3, compares the two excitation conditions.   Signal 
from serotonin, tryptophan, tyrosine, and HIAA were readily detectable at both 
wavelengths.  Generally, the electropherogram using 264 nm excitation contains more 
detectable analytes than 229 nm excitation, likely due to the accessible power at 229 is 
lower than at 264 nm.   
 
2.5 Conclusions  
A CE system equipped with a wavelength-resolved detector provides sensitive 
detection and analyte identification for metabolites of the amino acids tryptophan and 
tyrosine.  The LODs for these analytes have been shown to be well within physiological 
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levels of neural systems (low nanomolar) and competitive with the current state of the art 
in the field of trace analysis from neural systems in addition to yielding information-rich 
spectral data.  Excitation at 229 nm is applicable to a wide range of biologically relevant 
compounds, Fig. 2-2, and to extracts from the CNS, Fig. 2-3.  Outlined in later chapters 
of this dissertation this instrument has been used for a number of tryptophan-related 
measurements within a range of model neuronal systems.  As tryptophan is the precursor 
to a number of neuroactive compounds the ability to measure them at trace levels from 
volume-limited samples is of high importance.  The update of this instrument was 
intended to enhance our laboratories ability to measure these metabolites at even lower 
levels and higher throughput for the investigation of biological systems of interest. 
 
2.6 Future Directions 
The CE-LINF instrument has proven to be a valuable asset in the investigation of 
tryptophan and tyrosine metabolism within neural systems and can be further developed 
with improved hardware and software.  While substantial improvements in LODs, 
readout speed, versatility, and sample throughput have been made over the previous 
versions of this instrument, continued development in the areas of automation for both 
data analysis and sample handling, would increase the general applicability of the 
method.  Automated liquid handling would have the advantages of increased 
reproducibility between samples as well as increased throughput.  Automated methods 
for data analysis using peak finding software would significantly increase the throughput 
of data analysis.  Also, the parameters describing the shape of the Gaussian filter was 
optimized for average peak shapes observed.  However, various peak shapes in both the 
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spectral and temporal domains often occur.  Application of a “smart” filter which would 
choose the optimal parameters for the local data environment would increase the quality 
of the data without the need for manual manipulation.   
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2.7 Tables and Figures 
Analyte 
LOD264 nm 
 (nM) 
LOD229 nm  
(nM) 
Previous System 
LOD257 nm (nM)
59
 
Tryptophan 5 8 9.8 
Serotonin 1 5 5.6 
Tryptamine 1 6 4.3 
5-Hydroxy Indole 
Acetic Acid 
50 27 NA 
Tyrosine 88 47 45 
Dopamine* 36 23 120 
Epinephrine* 94 23 60 
Norepinephrine* 91 22 3900 
Octopamine 6 16 42 
Kynurenic Acid 50 14 NA 
Kynurenine 16 ND NA 
 
Table 2-1  Limits of detection for natively fluorescent, neuroactive compounds from the 
updated instrument at both 264 nm and 229 nm as well as our previous wavelength-
resolved system, demonstrating the improvements in sensitivity.  The limits were 
determined based on a 2 µM standards. * Separations performed in 25 mM citric acid 
with all other performed in 50 mM borate. NA – Not applicable ND – Not detectable
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Fig. 2-1  Diagram and photographs of the updated and enhanced wavelength-resolved CE-LINF instrument.  A.) Injection stage and 
nanovials used for volume-limited samples as low as 100 nL.  B.) Spectrograph and UV enhanced CCD array.  C.)  Argon-ion, 
frequency-doubled laser with variable outputs of 229, 257, and 264 nm for efficient excitation of both catecholamines and 
indolamines.  D.) Sheath-flow assembly allowing for post-capillary excitation to limit scatter and background fluorescence. 
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Fig. 2-2  Wavelength-resolved 
electrophoregram for a 
multianalyte standard set 
including a variety of biologically 
relevant, natively fluorescent 
compounds (Top). Normalized 
fluorescence spectra from signals 
within the white rectangle are 
provided in the bottom figure 
demonstrating the ability to 
identify closely eluting analytes 
based on spectral differences.   
Identified signals - 1.) tryptamine 
2.) serotonin 3.) octopamine 4.) 
tyramine 5.) dopamine 6.) 
tyrosine 7.) tryptophan 8.) 
norepinephrine 9.) tyrsoine 10.) 
sulforhodamine 101  11.) 5-
hydroxy indole acetic acid 12.) 
kynurenic acid 13.) FMN 14.) 
fluorescein 15.) NAD 16.) 
NADPH 
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Fig. 2-3  Wavelength-resolved electropherograms of brain stem extract at 229 m (panel A) and 267 (panel 
B). Several identifiable peaks are observed using both excitation wavelengths.  Identified analytes include 
(1) serotonin, (2) tryptophan, (3) tyrosine, and (4) 5-hydroxy indole acetic acid. 
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Chapter 3 
 
Automated Method for Analysis of Tryptophan and Tyrosine 
Metabolites Using Capillary Electrophoresis with Native Fluorescence 
Detection 
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3.1 Introduction 
The metabolism of tryptophan (Trp) and tyrosine (Try) within neural systems 
produces a variety of signaling molecules, including neurotransmitters and 
neuromodulators.  The distribution and tissue-specific levels of these metabolites can be 
correlated with functional, behavioral, and pathologic states.  For example, serotonin, a 
neurotransmitter derived from Trp, is well-known as a modulator of mood.  It is also 
critical to functions such as circadian rhythm, neurogenesis, memory, learning, and body 
temperature regulation, and has been implicated in pathologies including depression, 
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schizophrenia, and bipolar disorder.
1
  Analytical techniques for measuring the abundance 
and distribution of these metabolites within the brain are made challenging by its 
complex cellular organization and the often vanishingly small quantities of analytes and 
sample volumes available for analysis.  The latest human metabolome database
2
 reported 
more the 6800 identified metabolites, demonstrating the demand for selective and 
information-rich analytical techniques capable of examining chemically complex 
environments that consist of lipids, proteins, peptides, salts, and, the focus of this work, 
small-molecule metabolites.  While universal characterization approaches such as liquid 
chromatography (LC) mass spectrometry (MS)
3
 and nuclear magnetic resonance
4
 offer 
great flexibility, the selectivity provided by separations hyphenated to electrochemical 
(EC) and laser-induced fluorescence (LIF) detection offers advantages for investigating 
many analyte classes, in applications ranging from clinical analysis to basic research. 
Capillary electrophoresis (CE) is well-suited for the analysis of trace-level 
signaling molecules due to its small sample-volume requirements (nanoliter to 
femtoliter), high separation efficiencies (more than 10
6
 theoretical plates), and online 
sample concentration techniques, as reviewed by Lapainis et al.
5
  A variety of detection 
modalities are available for use with CE (e.g., EC,
6
 UV absorbance,
7
 LIF,
8-9
 and MS
10
).  
Oftentimes, the universal nature of these approaches and the high chemical information 
content they yield complements many studies.  However, selective detection provided by 
EC or LIF allows trace level characterization from complex samples as only a subset of 
the molecules within the sample are detected.  Both labeled and label-free methods can 
be used for LIF detection schemes.  Labeling target molecules by derivatization with 
highly fluorescent dyes can achieve high sensitivities, but it is difficult to achieve 
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efficient labeling of small-volume samples without causing analyte dilution.  In addition, 
non-specific and incomplete reactions can make analysis challenging, particularly within 
the chemically complex sample environment and limited sample volumes, such as those 
of interest in the present work.   
The quantitative nature of fluorescence is an advantage compared to other 
detection approaches.  Tryptophan and tyrosine metabolites both contain an aromatic ring 
with S0  S1 or S0  S2 transitions upon deep ultraviolet (DUV) excitation (200–300 
nm).
11
  These metabolites, along with Trp and Tyr containing peptides and proteins, have 
fluorescence quantum yields ranging from 0.13–0.28, which are sufficient to take 
advantage of this native fluorescence as a detection method at trace levels.
12-13
  Thus, 
native fluorescence is an attractive detection choice for both traditional and microchip CE 
systems.
14
  However, until recently, DUV excitation sources were large, costly, and/or 
high maintenance, thereby limiting wide-spread application of CE systems using native 
fluorescence.  The first CE, laser-induced native fluorescence (LINF) instrumentation 
used argon-ion (257, 305, and 275 nm)
15-17
 or frequency quadrupled Nd:YAG (266 nm)
18
 
lasers as excitation sources.  More recently, lower cost, stable DUV sources such as light 
emitting diodes
19-20
 and hollow-cathode metal vapor lasers
21
 have been employed in the 
effort to develop less expensive, more efficient detection systems. 
Here, we describe a prototype of an automated CE-LINF instrument used for the 
analysis of mammalian central nervous system (CNS) tissues and evaluate the analytical 
figures of merit for several neuroactive metabolites of tryptophan and tyrosine.  The 
design criteria included automated sampling, DUV excitation, and flexible emission 
wavelength detection.  The system uses a pulsed He-Ag, metal-vapor laser with a 224 nm 
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output for excitation, and tunable emission wavelength selection via a spectrometer, 
followed by detection with a photomultiplier tube, in many ways similar to systems we 
have reported on previously.
15, 21-22
  Prior CE instrumentation using DUV native 
fluorescence detection have been demonstrated to be effective for trace analyses of 
catecholamines and indolamines in chemically complex samples.
22-25
  However, the 
complexity and expense of both the excitation and wavelength-resolved (WR) detection 
instruments in these earlier systems have limited their general availability and slowed 
more widespread adoption of the technique.
21, 25-31
  The components of the instrument 
described here are relatively low-cost and can be installed on an existing automated CE 
instrument, allowing for high sample throughput and reproducibility.   
The applicability and performance of the automated CE-LINF system is 
demonstrated using brain stem tissue from rat brain and the results compared to those 
from a WR-CE-LINF system.  In addition to its ability to target selected metabolites, the 
prototype instrument is applicable to a wide range of other analyte classes via native 
fluorescence detection, including proteins and peptides containing Tyr and Trp residues.  
 
3.2 Experimental 
3.2.1 Chemicals, Solutions, and Materials 
Epinephrine, norepinephrine, dopamine, tyramine, tryptamine, citric acid 
monohydrate, 5-hydroxy indole acetic acid, melatonin, tryptophan, tyrosine, N-acetyl 
serotonin, glacial acetic acid, and methanol were purchased from Sigma Aldrich (St. 
Louis, MO, USA).  Serotonin was obtained from Alfa Aeser (Ward Hill, MA, USA). 
Chemicals for standards were purchased at the highest purity possible.  Ultrapure water 
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for stock solutions and standards was obtained from an Elga PureLab Prima water 
filtration system (Elga LLC, Woodridge, IL, USA) at a purity of 18.2 MΩ.  Fused-silica 
capillaries were obtained from Polymicro (Phoenix, AZ, USA).  
The extraction media consisted of 49.5/49.5/1, methanol (LC-MS 
grade)/water/glacial acetic acid (99%) by volume.  The background electrolyte (BGE) for 
separations was made by dissolving 5.25 g of citric acid monohydrate (25mM, pH 2.75) 
in 1.0 L of ultrapure water and sonicated to dissolve and de-gas.  Sodium hydroxide (0.1 
N), used for capillary conditioning, was obtained from Beckman Coulter Inc. (Brea, CA, 
USA). 
 
3.2.2 Preparation of Standards  
Individual, high concentration stocks for standards were prepared by weighing 1–
2 mg on a microbalance (Mettler Toledo; Columbus, OH, USA) and dissolving the 
analyte into the extraction media. Stocks were stored at –80°C until dilution to the 
working concentrations as indicated herein.  
 
3.2.3 Tissue Extraction and Quantitation 
Brainstem tissues were dissected from Sprague Dawley rats (Harlan, Inc., 
Indianapolis, IN, USA).  Animal euthanasia was performed in accordance with animal 
use protocols approved by the University of Illinois Institutional Animal Care and Use 
Committee, and local and federal regulations.  Brainstems were surgically removed 
immediately after animal decapitation by sharp guillotine.  The excised brain structures 
were flash frozen in dry-ice cooled isopentane and transferred into individual capped 
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plastic tubes and stored at –80oC until extraction.  Extraction media was added to the 
weighed tissue at a concentration of 5 µL/mg of wet weight.  The tissue was manually 
homogenized with the extraction media and allowed to extract for 90 min, centrifuged at 
16,000 g for 15 min, and the supernatant filtered using an Amicon 10 kDa molecular 
weight cut-off filter (Millipore; Billerica, MA, USA) at 4
o
C.   Samples were stored at –
80
o
C until analysis. 
Working curves were established using dilutions of high stock standards at 
concentrations of 1.00 µM, 500 nM, 250 nM 125 nM, and 62.5 nM.  Each concentration 
was analyzed in duplicate on the same day as the tissue analysis; linear regression 
analysis was used to determine the working equation. 
 
3.2.4 CE Separation Conditions 
The CE separations for both the automated and laboratory-built systems were 
performed using a BGE of 25 mM citric acid (pH 2.5) and an applied voltage of +30kV 
(18–20 µAmp).  The BGE was filtered using a 0.2 µm surfactant-free, cellulose acetate 
syringe filter (Nalgene; Rochester, NY, USA) immediately prior to use.  Between each 
separation, the capillary was conditioned for 1 min with 0.1 N NaOH at 15 psi and then 
rinsed with BGE for 2 min at 30 psi.  Total analysis time, including capillary 
conditioning, was approximately 10 min for each analysis. 
 
3.2.5 Automated CE-LINF System 
A prototype CE-LINF detection system was provided by Beckman Coulter, Inc.; 
its fundamental design has been previously described in application with an HPLC 
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system.
32
  Briefly, a hollow-cathode, He-Ag laser operating at 224 nm is used as the 
excitation source.  The incident angle for excitation is set at 30
o
 to reduce scatter and 
power loss.  Fluorescence is collected using a patented elliptical cell with the capillary 
and the spectrometer entrance slit positioned at the two foci.
33
   
We used a polyimide coated, fused silica capillary, 50 µm inner diameter (ID) × 
365 µm outer diameter (OD) and 48 cm in length, with a detection window created at 37 
cm.  The coating at the detection window was removed using a capillary window maker 
(MicroSolv; Eatontown, NJ, USA) in lieu of the more traditional open flame method to 
prevent excessive damage to the capillary surface.  The bare fused-silica of the detection 
window was cleaned by sonication for 10 min in ethanol and any remaining debris 
removed using optical lens paper (Thor Labs; Newton, NJ, USA).  Care was taken to 
clean and protect the surface of the detection window as contaminates and/or defects 
both on and in the surface of the capillary can increase background and scattering 
significantly, particularly when using DUV radiation. 
 
3.2.6 CE-WR-LINF System 
The limits of detection (LODs) and analyte identification of the automated CE-
LINF instrument were compared against those of a laboratory-built CE-WR-LINF system 
discussed in Chapter 2.
25, 34
  Briefly, this instrument uses 264 nm excitation (frequency 
double of the 528 nm fundamental) from an Innova FreD 300C argon ion laser (Coherent, 
Inc; Santa Clara, CA, USA).  We used a separation capillary with a 50 µm ID × 150 µm 
OD and a length of 50 cm, and post capillary excitation within a sheath-flow cell 
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containing 25 mM citric acid.  The resulting fluorescence spectra were imaged onto a 
charge-coupled device by a flat-field corrected spectrograph.  
 
3.2.7 Automated System Optimization  
In order to determine the optimal detection wavelength for the analytes of interest, 
the fluorescence emission was scanned using the automated CE system.  Each analyte 
was dissolved at a concentration of 10 µM in ultrapure water and flowed through the 
capillary using a positive pressure of 15 psi.  Fluorescence spectra were scanned from 
approximately 200–600 nm and the resulting spectra were normalized to the peak 
intensity after background subtraction (Fig. 3-1).  Subsets of these analytes that had peak 
intensities at similar wavelengths were separated into two sets of standards for 
evaluation—Set A: serotonin, tryptophan, and tryptamine, and Set B: tyrosine, dopamine, 
epinephrine, norepinephrine, and tyramine.  Both sets were evaluated using a grating 
position of optimal fluorescence for the individual set of analytes, as indicated by the 
vertical lines in Fig. 3-1. 
In order to determine the sample volume for optimal reproducibility, varying 
volumes of standard Set A were pressure-injected and the RSD calculated.  Solutions 
were injected using a pressure of 0.5 psi and the duration was varied from 3–25 s, with 
total injected sample volumes ranging from 4 to 33 nL; injections at each volume were 
repeated five times.  The relative standard deviation (RSD) for both peak height and area 
were calculated for tryptamine, serotonin and tryptophan.  The injected volume with the 
lowest RSD for the analytes was 20 nL, and this volume was used for subsequent 
quantitative studies for both performance evaluation and tissue analysis. 
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3.2.8 Data Processing and Analysis 
Data was processed using Origin 8.0 (OriginLab Corporation; Northhampton, 
MA) for smoothing, background subtraction, and peak quantitation.  The Savitzky-Golay 
smoothing method was used to reduce the high-frequency noise from the 
electropherograms using a window of five data points and a 2
nd
 order polynomial fitting.  
The peak integration analysis function of the Origin software was used to subtract the 
background and quantify several peak parameters: migration time, peak height, full width 
at half maximum, and peak area. 
 
3.2.9 Evaluation of Analytical Performance 
LODs were defined as the concentration of analyte with a signal-to-noise ratio of 
3, with the signal as the peak fluorescence intensity of the particular analyte peak, and the 
noise as the standard deviation of the background immediately preceding the peak.  Each 
analyte was analyzed individually using a standard at a concentration of 500 nM and the 
data processed as described in the Data Processing and Analysis section above.  
Concentrations of 30, 20, 15, 10, and 5 nM for both standard sets were prepared from 
high-concentration stocks for the determination of the limits of quantitation (LOQs).  
Each concentration was analyzed at n = 5.  Analytes were considered quantitative at a 
particular concentration if the RSD was less than 20%.  Within-day, day-to-day, and total 
precision was evaluated over a period of five consecutive days using three concentrations 
of both standard sets: 1.25 µM, 312 nM, and 78 nM.  Each concentration was analyzed in 
triplicate each day.  Linearity was evaluated from 29 nM to 20 µM using mixed 
55 
 
standards. Both 1
st
 and 2
nd
 order regression was used to determine the linearity of the 
peak area.  
 
3.3 Results and Discussion 
3.3.1 Design and Application 
CE-LINF as a detection method has proven to be a powerful tool, applicable to a 
variety of fields of research.  It has been used for the discovery of new serotonin 
metabolites,
23
 and the study of single cells,
25, 27
 pharmaceutical metabolism,
35
 
environmental monitoring,
36
 and sequencing.
37-39
  Oftentimes, a hurdle for its general 
applicability is the cost and complexity of DUV excitation sources, which have been 
primarily limited to large-frame, gas-ion and quadrupled Nd:YAG lasers.  The hollow-
cathode HeAg laser emitting at 224 nm used here is economically competitive with other 
fluorescence-based excitation sources used in commercial CE detection systems.  
Excitation at 224 nm increases the sensitivity of catecholamines by accessing the S0  S2 
transition, which has a higher absorbance cross section than more traditional DUV 
excitation wavelengths (e.g., 257, 264, 266, 287 nm) that use the S0  S1 transition.
11
  
Sheath-flow detection cells are typically used for off-column excitation due to the high 
level of background and power losses associated with Raleigh scattering in DUV.
40-41
  
Here, the instrumentation is enhanced by using on-column excitation at an incident angle 
of 30
o
 to reduce the scatter and a patented ellipsoid excitation cell to collect a larger 
fraction of emitted photons as compared to traditional collection optics, making on-
column excitation competitive with more complicated off-column sheath-flow setups.  
This configuration allows for application of LINF detection on existing automated CE 
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instrumentation, poising the technique for ready implementation by laboratories currently 
using automated CE systems. 
When one tags an analyte with a fluorophore, the fluorescence properties of the 
tagged analyte tend to be dictated by the characteristics of the particular fluorescence tag.  
Native fluorescence, with its inherent information-rich nature, means that individual 
species will have differing maxima for their fluorescence spectra.  For optimal 
performance this requires that either the entire spectra be acquired or a predefined, 
optimal wavelength be determined and monitored for the analytes of interest.  Generally, 
tyrosine metabolites have maxima around 300 nm and tryptophan metabolites around 350 
nm.  Small changes in the functional groups near the aromatic rings result in subtle 
changes in the fluorescence spectra, creating the clusters of fluorescence maxima 
observed in Fig. 3-1.  Reconfiguration of the ring structure during metabolism can shift 
the fluorescence maxima substantially, as is the case for kynurenine and kynurenic acid.  
Here, the metabolites of interest were divided into two sets according to the 
grouping of the fluorescence maxima: Set A (tyrosine metabolites) and Set B (tryptophan 
metabolites).  The two detection wavelengths of each set were chosen to correspond as 
close to the maximum fluorescence for as many of the analytes as possible from each 
cluster.  The selected grating position for each is indicated by vertical lines in Fig. 3-1.  
Some of the analytes for which fluorescence spectra are included in Fig. 3-1 were 
insufficiently fluorescent at the chosen detection wavelengths and were excluded from 
the performance studies, specifically, kynurenine, kynurenic acid, phenylalanine, and L-
DOPA.  Electropherograms for each of the two sets are included in Fig. 3-2. 
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3.3.2 System Performance  
Both systems were evaluated for several figures of merit for each mixed standard 
set: LOD, linearity, LOQ, and precision across concentration ranges relevant to levels 
that are typical for biological systems.  LODs for the prototype system and our own 
laboratory-built, WR instrument
34
 are given in Table 3-1 for comparison of their 
performance.  The CE-WR-LINF system was somewhat more sensitive for indolamines 
(tryptophan, serotonin, tryptamine), likely due to a larger absorbance cross section for the 
S0  S1 at 264 nm for indolamines than catecholamines.  There was a substantial, more 
than 5-fold, improvement in the detection limits for the catecholamines with the 
automated CE-LINF over the WR system, also likely due to an increased S0  S2 
absorbance cross section, in this case at 224 nm. 
Typically, fluorescence demonstrates linearity across many orders of magnitude, 
with the limiting factor being the method used for detection.  Here, the gain settings were 
optimized for the detection of low concentration analytes, which limits the dynamic 
range, but is optimal for the analytes of interest in CNS tissues.  Even so, as summarized 
in Table 3-2, a minimum of two orders of magnitude of linearity was observed for the 
analytes with higher fluorescent yields (serotonin, tryptophan, tryptamine, tyramine) and 
three orders of magnitude for analytes with lower fluorescent yields (dopamine, 
norepinephrine, epinephrine, tyrosine). 
One of the many advantages of automated commercial CE systems is the level of 
precision that can be achieved by limiting several of the more common sources of 
variation inherent in laboratory-built systems.  Automated systems offer temperature-
controlled capillary environments and pressure-controlled sample injections, two 
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variables that can substantially degrade reproducibility.  Here, the variation associated 
with sample introduction was minimized by optimizing the pressure–injected volume.  
Fig. 3-3 clearly shows that the most reproducible injection volume is approximately 20 
nL.  Because LODs were not significantly dependent on injection volume, they were not 
taken into consideration when choosing the injection volume.  The intraday precision 
ranged from 1–11% for the lowest concentrations, and 1–2% percent for the highest 
concentrations (Table 3).  As expected, the total precision over five days was higher than 
intraday, but the data trending (not shown) showed a slight drift toward lower total signal, 
indicating a degradation of the standards or minor changes in alignment.  However, even 
with the minor change in signal, the precision is still excellent and comparable with many 
clinical assay performance characteristics. 
 
3.3.3 Analysis of Mammalian CNS Tissue Extracts 
The quantitation of trace levels of analyte from tissue extracts presents some 
challenges, namely, successful extraction of analytes from tissue while minimizing 
effects from interfering protein and peptides.  By adding methanol to the extraction 
media, we not only preserved the analytes from enzymatic degradation by deactivation of 
the enzymes, but sufficiently lowered the conductivity to provide field-amplified stacking 
to improve LODs and increase separation efficiencies.  While CE is somewhat tolerant to 
complex sample environments, excess amounts of proteins can coat the walls of the 
capillary, degrading performance.  This was mitigated in three ways. First, the total 
amount of protein present in the sample was reduced by using a 10 kDa molecular weight 
cut-off filter.  Second, a low pH separation buffer was chosen. At low pH, the silanol 
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groups on the capillary surface are protonated, limiting the attraction between the 
peptides and the surface.  Finally, conditioning of the capillary surface with 0.1 N of 
NaOH between each analysis removed any contaminants.  The amount of sodium 
hydroxide used to condition the capillary was kept at a minimum so as to preserve the 
capillary and reduce the frequency of replacement.  Flushing the capillary for 1 min at 15 
psi with 0.1 N of NaOH produced reproducible electropherograms for the tissue extracts.   
The analyses of rat brain stem tissue demonstrated the applicability of the 
automated CE-LINF instrumentation and method to achieve reproducible quantitation 
from CNS tissue extracts.  Comparison electropherograms, extracted at the same 
wavelength for the tissue extracts, are shown in Fig. 3-4 from both the automated CE-
LINF (Fig. 3-4a) and WR-CE-LINF (Fig. 3-4b) systems, with the full wavelength-
resolved electropherogram shown in Fig. 3-5.  The peaks quantified using the automated 
CE system are labeled in Fig. 3-4: serotonin, tryptophan, and one indolamine-like, 
unidentified peak.  Results were: serotonin, 1.25 (± 0.12) nmol/g; tryptophan, 10.6 (± 
0.37) nmol/g; and the signal for an unidentified peak, 3.64 (± 0.42) A.U.  While the two 
electropherograms are similar, minor differences between the two can be attributed to 
differences in the fluorescence responses between the two excitation wavelengths.  The 
utility of tunable monitoring of emission wavelength is further demonstrated by the 
wavelength-resolved electropherogram in Fig. 3-5.  The varying analyte bands detected 
here have spectra ranging from 300-500 nm.  Selecting optimal wavelengths for specific 
analytes of interest simplifies the electropherogram, reducing potentially interfering 
signals. 
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3.4 Conclusions  
An automated, cost-effective, and sensitive CE-LINF instrument provides a 
platform for routine analysis of tryptophan and tyrosine metabolites in complex sample 
matrixes.  The monitoring of a particular wavelength of fluorescence emission enables 
fast and efficient data processing as compared to WR systems, which result in more 
complex data output, requiring more time-consuming data analysis methods.  Using a 
single wavelength for detection substantially lowers the cost and maintenance over CCD 
or array detection platforms.  The system is made more versatile by a programmable 
spectrograph that allows the optimal detection wavelength to be selected and tailored to 
the analytes of interest.  We look forward to the commercial availability of this 
instrument for both research and clinical applications.  While metabolite applications 
have been emphasized here, CE-LINF with DUV is applicable to many areas, including 
general characterization of peptides and proteins.
16, 20, 42
  The advantages of fluorescence 
include its fairly constant response for many Try and Trp-containing proteins and ease of 
quantitation.  We expect the use of LINF to greatly expand with the availability of this 
detection modality for CE. 
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3.5 Tables and Figures 
 
 
 
 
Table 3-1 Summary of detection limits (S/N = 3) of the automated CE-LINF platform in 
comparison to CE-WR-LINF system. The LODs for the tryptophan metabolites detected with 
the automated system are competitive with the wavelength-resolved system, showing a 5-fold 
improvement for tyrosine metabolites.  
  
Analyte 
Automated System 
(nmol/L)/(Attomoles) 
(224 nm) 
Wavelength-Resolved System 
(nmol/L)(Attomoles) (264 nm) 
Tryptophan 18 / 342 5/50 
Serotonin 4 / 76 1/10 
5-HIAA 13 / 247 50/500 
Melatonin 6  / 114 NA 
NAS 9  / 171 NA 
Tyrosine 15 / 285 88/880 
Dopamine 16 / 304 36/360 
Epinephrine 16 / 304 94/940 
Norepinephrine 30 / 570 91/910 
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Table 3-2 Evaluation of linearity for the selected standards. Typical linearity descriptors 
are included, along with the coefficient for the 2
nd
 order polynomial, which indicates a 
negligible 2
nd
 order component to the fit. 
Analyte 
Linear 
Range 
(nM) 
R-Squared  
(1
st
 order 
regression) 
Intercept Slope 
2nd Order 
Coefficient 
Serotonin 40–1,250 0.9997 -0.12 0.0083 1.7x10-5 
Tryptophan 40–2,500 0.9951 0.16 0.0045 -4.5x10-7 
Tryptamine 40–1,250 0.9998 -0.09 0.0104 3.7x10-7 
Dopamine 40–20,000 0.9993 -0.02 0.0006 2.6x10-9 
Epinephrine 40–20,000 0.9995 0.10 0.0008 -2.7x10-9 
Norepinephrine 40–10,000 0.9991 0.10 0.0014 -1.2x10-8 
Tyramine 40–5,000 0.9959 0.07 0.0016 -7.2x10-8 
Tyrosine 40–10,000 0.9979 0.16 0.0016 -2.3x10-8 
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Table 3-3 Summary of within-day, day-to-day, and total precision for the seven metabolite standards used to evaluate 
the analytical merits of the methods used in this study.   
 
 
 
 
 
  Serotonin Tryptamine Tryptophan Tyramine Dopamine Epinephrine Norepinephrine 
Level 1 
(78 nM) 
Within-Day 1% 2% 8% 6% 11% 11% 10% 
Day-to-Day 14% 12% 13% 20% 36% 24% 14% 
Total 14% 13% 15% 21% 38% 26% 18% 
Level 2 
(312 
nM) 
Within-Day 2% 2% 4% 2% 6% 4% 3% 
Day-to-Day 9% 9% 10% 9% 10% 9% 9% 
Total 9% 9% 10% 9% 11% 10% 10% 
Level 3 
(1.25 
µM) 
Within-Day 1% 1% 2% 2% 1% 1% 1% 
Day-to-Day 4% 3% 3% 6% 8% 7% 7% 
Total 4% 3% 3% 7% 8% 8% 8% 
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Fig. 3-1 Fluorescence profiles for tyrosine metabolites (a) and tryptophan metabolites (b) 
were obtained using the automated CE-LINF by scanning the emission spectra of the 
analyte being flowed through the capillary. The differences in fluorescence maxima for 
the various metabolites require selection of a wavelength to monitor corresponding as 
close as possible to the maxima of the analytes of interest. Vertical lines denote the 
grating position for detection for each set of metabolites  
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Fig. 3-2 Stacked electropherograms of standard set A (tryptamine, tryptophan and 
tryptophan) and B (tyramine, dopamine, epinephrine, norepinephrine, and tyrosine) from 
the automated CE-LINF system. Electropherograms were monitored at the optimal 
wavelengths determined for each set. 
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Fig. 3-3 Optimization of injection volumes. Varying volumes of standard Set A were 
injected by applying pressure at 0.5 psi for varying durations. While there was minimal 
variation in the LODs between the different injection volumes, the intra-day precision 
was substantially improved at a volume of ~20 nL. 
 
 
67 
 
  
Fig. 3-4 Typical electropherograms for the same brain stem tissue extract from the (a) 
automated prototype CE-LINF instrument provided by Beckman Coulter, Inc. and the (b) 
laboratory built, wavelength-resolved instrument. The differences in capillary lengths 
between the two instruments account for the differences in migration times. The 
identified peaks from serotonin and tryptophan were aligned for comparison. While the 
electropherograms are similar, the differences can be attributed to individual analyte 
responses to the differing excitation wavelengths.  Time scales have been aligned using 
known peaks (numbered) Key: 1 – Unidentified, but quantified peak, 2 – serotonin, 3 – 
tryptophan, 4 – tyrosine, * – unidentified peak  
 
 
 
a 
b 
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Fig. 3-5 Analysis of the same tissue extract Fig. 3-4 using wavelength-resolved native 
fluorescence detection. Several of the peaks can be identified by comparison of spectral 
and migration times to standards.  The unidentified peaks are likely other tryptophan 
metabolites or tryptophan-containing peptides/proteins. Key: 1 – Unidentified, but 
quantified peak, 2 – serotonin, 3 – tryptophan, 4 – tyrosine, * – unidentified peak. 
  
* 
* 
* 
* 
* 
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Chapter 4 
 
Serotonin of Mast Cell Origin Contributes to Hippocampal Function 
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1
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the CE-LINF approach described in Chapter 2. Dr. Kate Nautiyal conducted the 
behavioral and physiological studies which are summarized in the introduction along 
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4.1 Introduction 
The hippocampus and the subventricular zone are areas of neurogenesis within 
the central nervous system (CNS).  The hippocampus is involved in spatial learning, 
memory consolidation, and depression.
2-4
  Serotonin levels significantly alter 
hippocampal function and associated behaviors both during development and throughout 
adulthood.
5-6
  Specifically, alterations in serotonin signaling within the hippocampus have 
been linked to rates of neurogenesis, changes in spatial learning, depression, and 
anxiety.
7-9
  The traditional model of serotonin production within the CNS is that the raphe 
nucleus cell bodies in the mid-brain produces serotonin and the afferents innervate and 
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deliver serotonin to the entire CNS.
10-12
  For many areas of the brain this experimental 
evidence follows the traditional model well.  Typically, when serotonergic projections to 
a specific brain region from the Raphe are ablated serotonin levels in target regions are 
depleted.
13
  However, when projections to the hippocampus are ablated only a 40-60% 
reduction in serotonin content is observed, indicating a possible source of serotonin other 
than that reported from the median raphe nuclei.
13-14
  An increasing number of 
investigations have implicated the immune system in the function of the hippocampus.
15-
18
  Interestingly, mast cells are located adjacent to the hippocampus and are a potential 
source of serotonin. 
Mast cells are hemopoetic cells that are born in the bone marrow and migrate into 
various tissues where they mature and are known to cross the blood-brain barrier and 
migrate to the CNS of several species including the rat, mouse, dove, vole, and human.
19-
21
  However, the specific number and distribution of mast cells within the neural tissue 
varies significantly between these species.  In fact, mast cell population can vary based 
on a number of physiological and environmental factors including, handling,
22
 sexual 
behavior,
23
 isolation,
24
 pain,
25
 and stress.
26
  More than 60 mediators, including histamine, 
serotonin, and cytokines, are known to be released by mast cells but the exact chemical 
compliment is dependent upon specific tissue environment and type of stimulation.
27-29
  
In recent years, the presence of serotonin within mast cells in a variety of tissues has been 
established in animals, including humans.
30-32
  Serotonin specific antibodies were used to 
reveal that mast cells within the CNS contain serotonin, but at an unknown level.
33
  This 
evidence provided the motivation for this study to determine if parenchymal mast cells in 
the CNS can contribute to the pool of serotonin of the hippocampus.  If this is indeed the 
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case, we ask the questions: How much can this relatively low-abundant cell population 
alter the hippocampal milieu?  
A mast cell deficient strain of mouse, C57BL/6-Kit
W-sh/W-sh
(W
sh
/ W
sh
), has been 
used extensively as a method to study mast cell biology in vivo.  This strain has a 
naturally occurring mutation in the white spotting locus, suppressing c-kit receptor 
expression and preventing differentiation of mast cells from their progenitor cells.
34
  Our 
collaborators at Columbia University have collected a significant amount of behavioral 
and physiological data detailing many differences between the mast cell deficient and 
their heterozygous litter mates.  Results of staining for brain mast cells in +/+, W
sh
/+, and 
W
sh
/W
sh
 are seen in Fig. 4-1A.
  
W
sh
/W
sh 
mice appear normal in the numbers of other 
hematopoietic cells and in locomotor activity, increasing the confidence that the observed 
physiological and behavioral differences are a result of mast cell deficiency.
35-36
  These 
investigations centered on physiological characteristics of the hippocampus and the 
behavioral traits known to be mediated by the hippocampus.  Physiologically, the deficits 
in neurogenesis were profound between the two populations.  The area within the 
hippocampus where neurogenesis occurs, the dentate gyrus, was 12.9% smaller in area, 
while the other major regions within the hippocampus were not significantly different in 
size.  The only other known area of neurogenesis within the CNS, the subventricular 
zone, which contains no mast cells, showed no differences in size or rates of neurogenesis 
between the two populations.  As Fig. 4-1C illustrates, the number of immature neurons 
in the dentate gyrus is significantly lower in the mast cell deficient strain. Behavioral 
tests were administered to determine anxiety, spatial memory, and hippocampal learning.  
Results showed deficiencies in spatial memory and hippocampal learning as well as 
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increased levels of anxiety.  Fig. 4-1D demonstrates the dramatic difference in spatial 
memory by use of the Morris water maze.  Mast cell deficient mice were slower to learn 
the location of the hidden platform as compared to littermates.  While administration of 
fluoxetine ameliorates the deficit in neurogenesis behavior does not recover - implicating 
a more profound developmental role for mast cells in the brain. 
We have studied the chemical content of the hippocampus of W
sh
/W
sh
 and W
sh
/+ 
strains for possible metabolomic differences.  A laboratory-built instrument hyphenating 
capillary electrophoresis separation with electrospray ionization mass spectrometry 
detection
37
 was used to profile the global chemical content of the hippocampal extracts 
for statistically significant differences.(Unpublished)  Of the 41 metabolites monitored 
the 11 analytes that were at statistically lower levels in the mast cell deficient population 
were choline, nicotinamide, leucine, hypoxanthine, lysine, met, histidine, tyrosine, 
carnosine, glycine, and alanine.  The results of these studies suggest that mast cell 
signaling has a profound effect of the chemical composition of the hippocampus and 
further study is warranted. 
The chemical investigations of the hippocampus were initiated to support the 
physiological, behavioral, and emotional evidence obtained by our collaborators 
describing significant deficits in the mast cell deficient model.
35
  Our primary goal was to 
determine if serotonin is released into the hippocampus upon stimulated release of mast 
cells and, if so, how much do these low-abundance cells alter the hippocampal serotonin 
level.  Quantitative measurements were made using the CE-LINF instrumentation 
described in Chapter 2. 
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4.2 Experimental 
4.2.1 Mast Cell Deficient Mouse Model 
C57BL/6 wild-type (WT) and mast cell deficient W
sh
/W
sh
 mice (B6.Cg-KitW-
sh/HNihrJaeBsmJ, C57BL/6 background) were purchased from Jackson Laboratories 
(Bar Harbor, ME, USA) and bred to establish colonies at Columbia University animal 
facilities.  The W
sh
/W
sh
 mice were crossed with WT C57BL/6 mice, to generate 
heterozygote (W
sh
/+) mice which have mast cells. 
 
4.2.2 Chemicals 
Sigma-Aldrich (St. Louis, MO, USA) was the source for all chemicals and 
standards, unless otherwise noted.  Ultrapure water for buffers, standards, and other uses 
was generated by an Elga Purelab water system (U.S. Filter; Lowell, MA, USA).  
Methanol was of LC-MS grade (Chromasolve; Sigma Aldrich).  Water used for the 
preparation of the extraction media was LC/MS grade water (Thermo Scientific, 
Waltham, MA, USA).  Hank’s balanced salt solution (HBSS) was obtained from 
Invitrogen (Carsbad, CA, USA). 
 
4.2.3 Standards and Solutions 
Extraction media was made using 49.5% Methanol, 49.5% water, and 1% acetic 
acid by volume. Multi-analyte standards were made by dissolving high purity analytes in 
extraction media of the same composition as that used for the extraction of hippocampal 
tissue.  Included analytes were serotonin, tryptophan, 5-hydroxy indole acetic acid (5-
HIAA), and n-acetyl serotonin (NAS).  Separation buffer was borate (50 mM, pH 9.5) 
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and was made adding 9.2 g of sodium borate and 3 g of boric acid with 1.0 L ultrapure 
water.  Sheath-flow solution was citric acid (25 mM, pH 2.25) made by adding 5.25 g 
citric acid monohydrate to 1 L ultrapure water. 
 
4.2.4 Hippocampal Tissue Preparation  
For each animal, a 300 µm coronal slice containing the rostral (bregma – 1.70 
mm) and caudal (bregma - 2.92 mm) hippocampus was cut on a vibratome in ice cold 
HBSS.  To measure the contribution of mediators of mast cell origin, degranulation was 
induced by applying 400 µL of Compound 48/80 (C48/80; Sigma Aldrich, St. Louis, 
MO, USA) at a concentration of 0.1 mg/ml in HBSS, while the mast cells contribution at 
baseline was examined after application of HBSS alone. The brain slice was incubated 
with either C48/80 or the HBSS vehicle for 3 min.  Next, the hippocampus was dissected 
out and placed into Eppendorf tubes, weighed, and manually homogenized in 20 µl of 
extraction matrix per mg of dissected wet tissue.  Homogenized tissue was incubated with 
the extraction matrix for 90 min at 4°C before centrifugation at 15,000 g for 15 min.  The 
supernatants were then transferred to PCR tubes and frozen at -80°C until CE-LINF 
analysis. 
 
4.2.5 CE-LINF Analysis of Hippocampal Tissue 
Each hippocampal extract was analyzed in triplicate using a laboratory-built CE-
LINF instrument equipped with a wavelength-resolved detector described in Chapter 2.  
Briefly, ~10 nL of the supernatant was hydrodynamically injected into a fused-silica 
capillary and +21 kV applied for separation.  Background electrolyte was 50 mM borate 
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and sheath liquid was 25 mM citric acid.  Eluting analytes were excited using 264 nm 
radiation from a frequency-doubled, argon-ion laser (Coherent, Inc.; Santa Clara, CA, 
USA).  The fluorescence emission was collected and the spectrum imaged onto liquid 
nitrogen cooled CCD array (Princeton Instruments; Trenton, NJ, USA) where it was 
recorded at a rate of 2 Hz.  An example of the resulting wavelength-resolved 
electropherogram is provided in Fig. 4-2. 
 
4.2.6 Data Analysis 
Analyte bands were identified by comparison of both migration time and 
fluorescence emission characteristics to those contained in the standard.  For quantitation, 
analytes bands for both samples and standards were quantified by integrating the signal 
across both time and wavelength.  Standards at concentrations of 1000, 500, 250, 125, 
and 62.5 nM were used for the working curves.  The mass of serotonin was normalized to 
the mass of dissected hippocampal tissue.  The signal from tyrosine was normalized to 
the standard serotonin signal from the 1000 nM standard as tyrsoine was not originally 
included in the multi-anlayte standard set.   
Statistical differences in the populations were evaluated by the Kruskal-Wallis 
non-parametric analysis using Origin 8.0.
38
  The non-Gaussian statistical treatment was 
chosen because the total number of biological replicates for each population ranged from 
5 to 9.  More common Gaussian statistics such as ANOVA and the Students t-test rely on 
a sufficiently large number of samples to establish a Gaussian distribution.  Outlying data 
points were removed based on the results of the Q-test.  If either of the two sections of 
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hippocampus were found to be a statistical outlier the corresponding data for the 
remaining section of hippocampus from the same animal was removed. 
 
4.3 Results and Discussion 
Mast cells are found throughout the body and play key roles within the immune 
system, but as of yet their specific actions within the CNS has undergone relatively little 
investigation.  Although, a dramatic report shows that blocking mast cell release during 
hypoxia-ischemia decreases brain injury and atrophy in the long term.
39
  As seen in Fig. 
4-1A, mast cells lie within and near the hippocampus. Upon activation, mast cell granules 
release their contents over a substantial volume of tissue.
35
  Thus, following 
degranulation, the distribution of granular contents from mast cells lying both within and 
nearby the hippocampus can be measured.  This paradigm provides a method to study the 
levels and distribution of mast cell release within the brain.  However, due to complete 
degranulation upon activation with compound 48/80, this model represents the highest 
levels of analytes that are prepackaged and ready for release at the time of stimulation.  
Specifically, here we use this genetic variant to determine the amount of serotonin mast 
cells may contribute to the hippocampal milieu.  
 
4.3.1 Serotonin Results  
In the rostral hippocampus no significant differences between W
sh
/+ (n=4) and 
W
sh
/W
sh
 (n=5) mice in baseline levels of serotonin were measured following application 
of HBSS vehicle (H1=0.00, p>0.05; Fig. 4-4).  Additionally, following the application of 
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C48/80, there were no differences in serotonin content in the rostral hippocampus 
between W
sh
/+ (n=7) and W
sh
/W
sh
 (n=7) mice (H1=0.10, p>0.05), Fig. 4-4  
 In the caudal hippocampus, there were no significant differences between W
sh
/+ 
and W
sh
/W
sh
 mice in baseline levels of serotonin measured in HBSS vehicle condition 
(H1=0.02, p>0.05;).  In contrast, following application of C48/80 to the slices, serotonin 
content in W
sh
/+ mice (n=7) was increased compared to their HBSS baseline and to that 
of W
sh
/W
sh
 (n=8) mice (H1=6.48, p<0.05).  Approximately 50% more serotonin was 
measured in W
sh
/+ mice compared to W
sh
/W
sh
 mice in C48/80 stimulated caudal 
hippocampus.  This represents a dynamic mast cell-mediated increase in serotonin to the 
hippocampus.  Interestingly, this increase corresponds to the larger population of mast 
cells resident near the caudal vs. rostral hippocampus and indicates that degranulation of 
mast cells in brain tissue contributes measurable levels of this neurotransmitter to the 
hippocampal milieu.  
 In an experiment comparing the serotonin levels of the caudal portion of the 
hippocampus for WT, heterozygous, and homozygous mice a possible reduction in 
serotonin variation in the mast cell deficient mice as compared to the WT strain in non-
degranulated hippocampal slices was observed.  Given the high variability of the number 
of mast cells the lower variability shown in Fig. 4-3B for the mast cell deficient strain is 
not too surprising.  However, in the experiments when mast cells were degranulated this 
trend was not observed. 
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4.3.2 Tyrosine Results 
Levels of tyrosine in W
sh
/+ and W
sh
/W
sh
 animals did not change with mast cell 
stimulation by C48/80, Fig. 4-4, in either the rostral or caudal sections of the 
hippocampus.  However, the basal level of histamine between the two populations was 
statistically different without regard to stimulation of mast cell release in the caudal 
portion, the area of the hippocampus near larger populations of mast cells.  Tyrosine is 
not known to be synthesized or released from mast cells and the data collected here 
illustrates the difference in concentrations between W
sh
/+ and W
sh
/W
sh
 is independent of 
mast cell stimulation.  These results supports the assertion that hippocampal chemical 
content is altered beyond direct contributions such as that observed from serotonin which 
we have demonstrated here. 
 
4.3.3 Chemical Analysis in Support of Behavioral and Physiological Results 
The physiological and behavioral data published along with these results present 
compelling evidence that mast cells are integral to normal hippocampal functioning and 
development.  Deficits in neurogenesis, spatial memory, learning, and anxiety have all 
been linked to dentate gyrus function and correspondingly modulated by serotonin 
levels.
40-41
 As has been demonstrated in the corresponding publication to this work, 
neurogenesis may recover with selective serotonin reuptake inhibitor, fluoxetine, 
administration but behavior is not recovered, suggesting a more fundamental role of mast 
cells during development. 
While the serotonin results reveal the direct mast cell influence to the 
hippocampus, the results of tyrosine measurements indicate possible secondary changes 
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in the chemical content of the hippocampus resulting from mast cell presence.  The 
difference of tyrosine was confirmed by the CE-ESI-MS metabolomics analysis of these 
samples increasing the confidence that measured changes are not likely attributable to 
statistical variations.  The profound effect the lack of mast cells has on hippocampal 
metabolism is surprising considering the mast cell population only makes up less than 
0.1% of the total hippocampal cells. 
 
4.4 Conclusions 
The analysis of serotonin content of the hippocampus represents the first 
quantitative measurement of serotonin contribution to the hippocampus by mast cells.  
We have demonstrated that mast cells can contribute significant amounts of serotonin to 
the hippocampus when stimulated by compound 48/80 to release stored granules.   The 
results here add even more evidence that link cells associated with the immune system to 
neural functioning.
15-17, 42
 
The observed serotonin increase was specific to the area of the hippocampus 
adjacent to the parenchymal mast cell population whereas the serotonin levels in rostral 
portion of the hippocampus were not significantly changed upon mast cell stimulation.  
This data along with the behavioral and physiological results show a profound effect of 
mast cells on both hippocampal functioning and chemical content.  Given the relatively 
low abundance and variability of the number of mast cells within the brain, such striking 
and profound changes will hopefully promote further studies into their role in 
neurological functioning and pathologies. 
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4.5 Future Directions 
This work has demonstrated that mast cells can have a profound influence on the 
hippocampus which is integral to many of the most fundamental functions of the brain 
including learning, memory, and spatial reasoning even though they represent less than 
0.1% of the total number of cells compared to the entire hippocampus.  The significant 
roles of serotonin, both as a neurotransmitter and trophic factor in the hippocampus, in 
mediating mood, neurogenesis, and body temperature require an in-depth understanding, 
warranting further investigations.  Now that the significant impact mast cells can have to 
the hippocampus at the adult stage, more specific questions of mast cells involvement in 
the development of the hippocampus is of interest.  Further studies should focus on the 
additional mediators mast cells could release in paradigms that investigate development 
and pathological conditions in which mast cells are known to be activated.
85 
 
4.6 Figures 
 
 
 
 
 
 
 
 
 
 
 
 
5 µm 
A B 
C 
Fig. 4-1  Summary of behavioral and physiological results performed by our collaborators.  A.) Distribution of mast cells plotted on a 
sagittal diagram of the mouse brain.  Areas corresponding to the hippocampus are marked in pink with mast cells marked as blue dots.  
B.) An individual mast cell stained with touludine blue with the individual granules visible.  C.) The dentate gyrus stained with DCX to 
visualize immature neurons.  D.) Performance comparison in the Morris water maze with the platform both hidden and visible.  Mast 
cell deficient mice (solid line) show a significantly longer time to escape than mast cell competent mice. Nautiyal, K. M.; Dailey, C. A.; 
Jahn, J. L.; Rodriquez, E.; Nguyen, H. S.; Sweedler, J. V.; Silver R. Serotonin of Mast Cell Origin Contributes to Hippocampal 
Function. European Journal of Neuroscience 2012,  (In Press). Adapted with permission. 
D 
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Fig. 4-2 Example of the wavelength-resolved electrophoreograms from the analysis of 
hippocampal samples. (a) Serotonin, (b) neutral analyte band, (c) tryptophan, (d) tyrosine, 
and (e) 5-hydroxy indole acetic acid. 
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Fig. 4-3 A.) Counts of mast cells present in coronal hippocampal slices. B.) Measurement 
of serotonin levels in genetically matched wild type (WT), heterozygous (Het), and 
homozygous (SASH) littermates. 
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Fig. 4-4 Effects of mast cell degranulation on hippocampal serotonin content in mast cell 
deficient W
sh
/W
sh
 and W
sh
/+ mice. Increase in serotonin content of the caudal 
hippocampus (~50%) in mast cell-competent mice (W
Sh
/+) upon stimulation correlates 
with the co-localization of mast cells to the caudal but not rostral portion of the 
hippocampus. Likewise, no increase is observed in the mast cell-deficient mice (W
Sh
/W
Sh
) 
(p=0.01 using Kruskal–Wallis one-way analysis of variance). Tyrosine, a non-mast cell 
related analyte is lower in concentration between the two populations but is not changed 
by degranulation.  Error bars indicate standard error. Nautiyal, K. M.; Dailey, C. A.; 
Jahn, J. L.; Rodriquez, E.; Nguyen, H. S.; Sweedler, J. V.; Silver R. Serotonin of Mast 
Cell Origin Contributes to Hippocampal Function. European Journal of Neuroscience 
2012,(In Press). Adapted with permission. 
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Chapter 5 
 
Detection of Kynurenine and Kynurenic Acid Using Wavelength-
Resolved Capillary Electrophoresis 
 
Notes and Acknowledgements 
This chapter focuses on the extension of the system described in Chapter 2 to 
include an increased number of tryptophan metabolites.  I would like to thank Dr. Peter 
Yau at the Biotechnology Center for his discussions about tissue extraction protocols.  
Funding for this work was provided by National Institute of Neurological Disease and 
Stroke through NS031609 and the National Institute of Dental and Craniofacial Research 
through DE018866. 
 
5.1 Introduction 
Tryptophan is an essential amino acid used in protein synthesis and is also 
involved in several important metabolic pathways.  As outlined in prior chapters these 
include the synthesis of serotonin. The majority, more than 90%, of tryptophan 
metabolism in mammals is through the kynurenine pathway (KP).
1
  Within this pathway 
oxidation of tryptophan occurs by one of two enzymes: tryptophan 2,3-dioxygenase
2
 
(TDO) primarily located in the liver and indoleamine 2,3-dioxygenase
3
 (IDO) which is 
found in  rest of the body, including the central nervous system (CNS).
4-6
  As tryptophan 
is an essential amino acid, the total, available pool is limited to dietary intake, making KP 
metabolism interesting, not only for the direct metabolites it produces, but the potential 
secondary effects on other metabolic pathways based on changes in precursor availability 
such as the synthesis of serotonin.
7
  Even though serotonin production represents only a 
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small fraction of the total tryptophan metabolism it has undergone significant research,
8-11
  
while methods for KP metabolites have undergone limited development. 
The downstream metabolites include the neuroactive compounds kynurenine, 
kynurenic acid, and quinolicic acid.  These metabolites have both neuroprotective and 
neurotoxic actions on the brain.
5
  The first stable metabolite, kynurenine, has not been 
shown to have a direct action on neurons, but there is some evidence of signaling for 
nerve growth factor production from glial cells.
12-13
  Kynurenic acid is formed from 
kynurenine by the enzyme kynurenine aminotransferase
14
 (KAT) which is preferentially 
localized in glial cells and exhibits anticonvulsant and neuroprotective properties.
15
  
Kynurenine not converted to kynurenic acid continues along the metabolic pathway to 
produce nicotinamide adenine dinucleotide (NAD). One neuroactive metabolite in that 
branch, quinolinic acid, is an N-Methyl-D-aspartate (NMDA) receptor agonist and can be 
excitotoxic to these neurons.
16
  Depending on the expression of these enzymes in local 
environments tryptophan metabolites can be either neuroprotective or neurotoxic. 
Pro-inflammatory cytokines can induce or suppress expression of IDO, 
dramatically changing the fate of tryptophan in local environments.
17
  For example, 
expression of IDO has been shown to be upregulated by IFN-α, IFN-γ, and TNF-α.18  As 
these cytokines are regulated by the immune system IDO expression is largely controlled 
by the immune system,
19
 linking the biochemical content of the brain to the activity of the 
immune system.
20-21
  In fact, it is interesting to note that SSRIs and SSNRIs have been 
shown to target proinflammatory cytokines known to reduce neurogenesis.
22-23
  The 
relationship between specific KP metabolites and numerous pathologies of the CNS are 
reviewed by Stone (and illustrated in Figure 5-1).
24
  Briefly, KP metabolites deviate from 
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homeostatic levels in neurodegenerative diseases including Huntington’s, Alzheimer’s, 
and multiple sclerosis as well as chronic infections such as Lyme disease, malaria, and 
AIDS.
25
   Activation of the immune system is correlated in large changes in KP 
metabolites in blood resulting from trauma ranging from a chronic brain injury
26
 to 
hypoxic ischemia.
27
  With neurogenesis being related to physiological symptoms of 
depression, this further supports the inflammatory theory of depression.
16
  The impact of 
KP metabolites on the CNS has created interest in developing pharmaceutical-based 
therapies.
24, 28-29
   
 Current methods for the detection and quantitation of KP metabolites have 
focused on analysis of the biofluids plasma/serum, cerebrospinal fluid (CSF), and urine 
as outlined in Table 5-1.  The most common technique for clinical research has been 
HPLC with ultraviolet (UV) absorbance or fluorescence detection.
30-31
  These techniques 
have shown a complex relationship between the metabolism of tryptophan and numerous 
diseases.  Many of these changes only correlate with pathologies.  However, more 
detailed, mechanistic investigations need sufficiently sensitive methods capable of 
measuring these levels from tissue.  This has been partially addressed by the analysis of 
microdialysates to measure in vivo levels.
32
  While these prior studies used LC 
techniques, investigations using CE have been limited.  CE would allow volume-limited 
samples to be analyzed, aiding the analysis of tissue samples from the CNS.  The 
reported CE methods have detection limits in the low nM range, competitive with the 
HPLC methods. 
Here we extend our CE with wavelength resolved LINF detection
33
 to include 
detection of KP metabolites kynurenine and kynurenic acid.  The work includes 
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investigations to optimize the fluorescence yield using either Zn
2+ 
or nonaqueous buffers 
to improve sensitivity by increasing the fluorescence yield. 
 
5.2 Experimental 
5.2.1 Chemicals, Solutions, and Materials 
Standards and chemicals were obtained from Sigma-Aldrich (St. Louis, MO, 
USA) at the highest purity possible unless otherwise noted. Serotonin was purchased 
from Alfa Aeser (Ward Hill, MA, USA).  Water for solutions and standards was obtained 
from an Elga PureLab Prima water filtration system (Woodridge, IL, USA) at purity of 
18.2 MΩ.  
Extraction media consisted of 49.5/49.5/1, methanol/water/glacial acetic acid 
(99%) by volume.  Standards were weighed (1-2 mg) on a microbalance (Mettler Toledo; 
Columbus, OH, USA) and dissolved in extraction media for high concentration stock 
solutions.  These stocks were stored at -80°C until use for dilution to working 
concentrations. Borate buffer was prepared at 50 mM at a pH of 9.5 and citric acid was 
prepared at 25 mM  at a pH of 2.5.  Both the citric acid and borate buffers were filtered 
using a 0.22 µm vacuum filter and degassed by maintaining the vacuum for 20 min while 
stirring.  
 
5.2.2 Absorption spectra 
Because many of the analytes in the KP are not spectroscopically characterized, 
we obtained absorption spectra to determine if detection is possible with LINF at the 
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available wavelengths of 264 or 229 nm.  Absorption spectra were obtained using 
standards dissolved in 50 mM borate at a concentration of 1 µM. 
 
5.2.3 Capillary Electrophoresis Analysis 
A laboratory constructed CE-LINF system was used to perform all measurements 
as described in Chapter 2 with modifications detailed below.
33
  The CE separations were 
performed using 50 mM borate (applied voltage +21 kV) and 25 mM citric acid used in 
the sheath flow.  Approximately 10 nL of sample was hydrodynamically injection into 
the capillary by lowering the outlet for 30 s. 
Limits of detection reported in Table 5-3 were defined as the concentration of 
analyte with a signal-to-noise ratio of 3 with the signal as the peak fluorescence intensity 
of the particular analyte and the noise as the standard deviation of the background 
immediately preceding the peak from the extracted electropherogram. 
 
5.2.4 Modifications for Non-Aqueous Solvents 
High Purity perfluoro alkoxy alkane (PFA) (PN1640; Upchurch Scientific; Oak 
Harbor, WA, USA) tubing replaced the previous Tygon
®
 tubing for non-aqueous sheath-
flow or separations.  The metering valve used to regulate the sheath-flow rate was 
replaced with a newer model using Teflon for all liquid contacting components (Cole-
Parmer; EW06394-00; Vernon Hills, IL, USA). 
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5.3 Results and Discussion 
Of the tryptophan metabolites outlined in Fig. 5-1, serotonin, tryptophan, 
tryptamine, NAS, melatonin, HIAA, kynurenine, kynurenic acid, NAD, NADPH are all 
detectable our by CE-LINF system.  These compounds represent the majority of the 
known, stable, and bioactive metabolites within the tryptophan metabolic pathway.  The 
available methods to date that have focused on measurement of KP metabolites have 
primarily been applied to the analysis of biofluids – serum, plasma, urine, and CSF with 
few techniques developed for their measurement within tissues.
4
  Table 5-1 summarizes 
many of the methods used for measuring KP metabolites and includes the reported 
detection limits.  The most widely used separation method is HPLC which has been 
largely used for clinical investigations.  With the ever increasing evidence of the effects 
these metabolites have on the CNS, microscale methods compatible with samples of 
limited volume that are typical in neuroscience studies will be necessary.  While a limited 
number of CE methods have been developed which have competitive sensitivities, their 
more wide spread use has been limited.  These methods have used a number of detection 
methods including mass spectrometry,
34
 UV absorption,
35
 fluorescence,
36
 and 
electrochemical
32, 37
 with detection limits in the low nM range.  The primary motivation 
to use CE in this work is to take advantage of its compatibility with low-volume samples 
to measure KP metabolites from small brain regions which would be difficult in the more 
traditional HPLC systems. 
Our method using a separation buffer of 50 mM borate and a sheath liquid of 25 
mM citric acid resulted in detection limits that are competitive with other HPLC and CE 
techniques reported in Table 5-1.  Results from 1 µM standards are presented in Fig. 5-2 
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and Table 5-1.  The limits of detection were 50 nM for kynurenine and 15 nM for 
kynurenic acid (Table 5-3).  Reports of kynurenic acid levels in various areas of the brain 
have been previously reported to be between 18 and 29 pmol per gram of tissue, with the 
highest the concentration found in the brainstem Table 5-2.  Even at an extraction ratio of 
1 µL of media to 1 mg of tissue, which is very low, results would be at 28.9 nM 
concentration sample for the brainstem, below the detection limits using this standard 
protocol.  To accomplish detection within tissue the sensitivity of the method needs to be 
improved or approaches that concentrate the KP products from larger samples into a 
small enough volume to allow for detection developed. 
As the LODs of our current method were not sufficient for tissue analysis, we 
investigated two methods to increase the fluorescence quantum yield of kynurenine and 
kynurenic acid - non-aqueous separation and detection conditions as well as addition of 
Zn
2+
.  Non-aqueous separation and detection conditions were based on a thorough report 
of the excited-state dynamics of kynurenine by Sherin et al.
38
   Their study showed a 
significant increase in fluorescence quantum yield in non-aqueous over aqueous solvents.  
Reported increases were one order of magnitude for kynurenine dissolved in methanol 
and two orders of magnitude for dimethyl sulfoxide as the solvent as compared to water.  
The advantage of our sheath-flow setup is the ability to decouple separation and detection 
conditions.  A first choice test was to add non-aqueous solvents to the sheath-flow as the 
separation conditions were already developed.  Ultrapure solvents that were used as 
sheath-flow liquid included dimethyl sulfoxide, ethanol, methanol, and acetonitrile.  All 
of these solvents resulted in significant background when using 264 nm light as the 
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excitation source.  After replacing all tubing with more the chemically resistant PFA 
tubing, the background was improved, but still overwhelmed the CCD detector.   
Zn
2+
 has been shown to increase the fluorescence yield from KA.
39-40
  However, 
the increase in fluorescence is dependent on pH, with significant improvements in 
florescence above a pH of 6.  An improvement of an order of magnitude is reported at a 
pH of 6.75.  Here, A 100 mM zinc acetate solution for the sheath-flow conditions was 
used, but at pH conditions above 5, where increased fluorescence occurs, a precipitate 
formed on the capillary outlet, presumably zinc hydroxide, which disrupted excitation 
and eventually obstructed the capillary completely.   
 
5.4 Conclusions 
Here we have demonstrated that the CE-LINF instrumentation and method 
described in Chapter 2 is able to be expanded to include a broader range of tryptophan 
metabolism which include the kynurenine pathway metabolites kynurenine and 
kynureneic acid.  With the increasing interest and evidence of significant roles in 
connecting the brain with the immune system, new methods are needed for their analysis.  
The detection limits are comparable with those already reported and included in Table 5-
1, but the trace levels found in tissue make analysis difficult and even more sensitive 
methods are needed to expand this area of research. 
 
5.5 Future Directions 
Insights into the profound influence of the immune system on the brain through 
the metabolites of tryptophan via the KP is in the process of rapid expansion.  It is my 
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viewpoint that significant medical therapies will evolve from the mediation of the KP.  
Greater understanding of the mechanisms by which this pathway acts, the better targeted 
these new therapies can be and those studies will require highly sensitive analytical 
techniques.  While the performance demonstrated here is impressive, it is not yet 
sensitive enough for detection from tissue at endogenous concentrations.  From the 
increase in fluorescence yield reported by Sherin et al. efforts to use native fluorescence 
in non-aqueous solvents should be continued, but at longer wavelengths, ~350 nm, which 
is another absorption peak for kynurenine metabolites, Fig. 5-3.  This may allow the use 
of non-aqueous solvents to increase fluorescence while limiting the excess background 
observed by the current method at 264 nm.  The more traditional option for increasing the 
fluorescent yield of these metabolites is derivatization with a fluorophore.  An example of 
derivatization with kynurenine metabolites was demonstrated by Mitsuhashi et al.
41
  
These methods should be investigated given the therapeutic potential of KP metabolits. 
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5.6 Tables and Figures 
Separation 
Detection 
Method 
Analytes LOD Matrix Reference 
HPLC 
Tandem Mass 
Spec 
Trp 30 nM 
Human 
Plasma 
42 Kyn 1 nM 
3-HK 5 nM 
HPLC UV 
Trp 8 nmol Human 
Plasma 
30 
Kyn 6 nmol 
HPLC 
UV and 
Fluorescence 
Trp 7 mmol Human 
Serum 
31 
Kyn 2 nmol 
HPLC UV 
Trp 134 nM 
Human 
Plasma 
43 Kyn 16 nM 
5-HT 2 nM 
HPLC MS KynA 200 fmol 
Blood – 
Mouse 
44 
HPLC 
Tandem Mass 
MS 
Trp 17.6 nM 
Rat Plasma 45 
Kyn 17.3 nM 
KynA 17.5 nM 
QA 48.2 nM 
CE MS 
Trp 20 nM 
CSF 34 Kyn 20 nM 
KynA 20 nM 
CE LIF KA 1 nM CSF 36 
CE UV 
Trp 400nM Human 
Plasma 
35 
Kyn 150 nM 
CE EC 
Trp 4.8 amol 
Brain 
Dialysate 
32 
Kyn 3.1 amol 
3-HKyn 0.4 amol 
Anth. Acid 3.3 amol 
KynA 22.2 amol 
XA 0.6 amol 
CE-MEKC AD 
3-HK 7.42 nM 
Urine 37 
5-HTP 5.18 nM 
Kyn 34.6 nM 
Trp 3.99 nM 
5-HIAA 15.1 nM 
XA 12.7 nM 
5-HT 6.72 nM 
Trp 8.01 nM 
Table 5-1 Quantitative methods have been limited in development with the 
majority of methods targeting biofluids (serum, plasma, CSF, and urine). 
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Kynurenic Acid inTissues 
Region 
pmol/g Tissue 
wet Weight4 
fmol/mg protein39 
Cortex 18.1 32.5 
Hippocampus 27.1 54.9 
Cerebellum 17.9 63.6 
Brain Stem 28.9 149 
Striatum 23.2 51.6 
Biofluids 
      Kynurenic Acid Kynurenine 
Plasma40 24.7 nmol/L 2.2umol/L 
CSF39 5.09  
Analyte LOD264 nm (nM) 
Tryptophan 5.0 
Serotonin 1 
5-HIAA 50 
Kynurenine 50 
Kynurenic Acid 16 
Table 5-2 While tissue quantitation has undergone limited 
investigation, a few studies have provided insight to the target 
values for kynurenic acid in various parts of the brain. 
 
Table 5-3 Detection limits for major 
tryptophan metaoblites using 50 mM 
borate separation buffer and sheath-flow 
liquid using the wavelength-resolved CE 
system. 
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Fig. 5-1  Scheme of tryptophan metabolism in mammalian biology.
46-47
  The majority of tryptophan is metabolized by IDO or 
TDO into the kynurenine pathway. 
1, 47
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Fig. 5-2 Wavelength-resolved electropherogram of the major, natively fluorescence 
tryptophan metabolites.  Each analyte is at a concentration of 1 µM except 
sulforhodamine 101 which at a concentration of 20 nM. 
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Fig. 5-3 Absorbance spectra for the metabolites investigated.  While 
serotonin and tryptophan are optimal in the 250-300 nm after the ring 
rearrangement by IDO 350 nm might be applicable.  
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Chapter 6 
 
Investigation of Basal Phyla for Presence of Classical Signaling 
Molecules 
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6.1 Introduction 
The evolution of a central nervous system (CNS) was the corner stone for the 
occurrence of animal development. Cell-to-cell signaling in the CNS neurons and 
between neurons and other cell types allows the synchronization of activity and function, 
thus allowing coordinated behaviors in complex, multicellular organisms.  These nervous 
systems have their origins in early life with presynaptic proteins present in unicellular 
organisms.
1
  The theoretical, although still not completely described, common ancestor 
of most higher order animals is the now extinct Urbilateria, which would have diverged 
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around 600 million years ago.
2
  The evolution of neurons and the centralized nervous 
systems prior to this divergence are still under investigation without a predominate 
theory having been accepted.
3
  The evolutionary theories for the occurrence of complex, 
centralized nervous systems can be categorized into two broad concepts: monophyletic 
and polyphyletic in origin.
4
  In brief, a consensus has not been agreed upon if the CNS 
present in higher order life resulted from a single, ancient genome (monophyletic) or if it 
was a confluence of multiple evolutionary lineages (polyphyletic). 
Traditional evolutionary theories were based on the observation of morphological 
characteristics to determine phylogenic relationships.  Insights from molecular biology 
have changed the landscape in understanding evolution based on gene networks, a 
concept termed evolutionary developmental biology (Evo-Devo).
4-6
  The genes that 
control body patterning, development, and differentiation of the nervous system are more 
conserved across much of animal life than previously realized.
7-9
  This new insight for 
studying the evolutionary taxonomy substantially changed phylogenic relationships, 
particularly among basal phyla based on revelations in genomic similarities.
6, 10-11
  
Cnidaria and Ctenophora have been moved to sister phyla instead of basal to Bilateria.  
Just as genetic conservation provides insight into evolution, so does gene loss.  Many of 
the basic chemical signaling pathways and their synthetic pathways such as serotonin are 
well conserved from these early organisms, while others appear to have been lost.  Not 
all evolution leads to increased complexity; examples such as vestigial structures show 
decreased complexity/simplifications can occur. 
One of the tools in understanding the evolution of signaling pathways is to study 
these ancient nervous systems of basal species.
12
  While the CNS of Bilateria have been 
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studied extensively, information about systems present in more basal taxa is limited.
13
  
Ctenophores, also known as comb jellies, are primitive animals and represent one of the 
earliest occurrences of a differentiated nervous system with synapses. These animals 
diverged prior to the occurrence of Bilateria.  In fact, it is one of the most basally 
branching lineages of metazoan life, representing the early emergence of a neural system.  
However, the exact placement of Ctenophores along with Cnidaria and Porifera as sister 
phyla to Bilateria is largely unresolved due to a general lack of genomic and molecular 
studies on the species within these phyla.
5, 8, 13-15
 
One interesting genus of the Ctenophore phylum is the Pleurobrachia bachei, 
many of which are bioluminescent.
16
   These animals use a rudimentary, diffuse nervous 
system which is not centralized and is best described as a neural net.
17
  However, even 
without the advanced organization seen in higher species it can still feed, reproduce, and 
defend itself.  Immunofluorescent staining techniques have shown that Ctenophore 
neurons are both neuropeptidergic and heterogeneous, implying an interesting level of 
complexity for such a relatively simple system.
18
  These animals are one of the few major 
animals prior to Bilateria divergence without significant genomic studies available.
19
  
While genetic studies have redefined much of Bilateria it has not been successful in 
resolving the taxonomy of basal phyla – Ctenophores, Cnidaria, and Poriferans. 
The metabolism of tryptophan into serotonin (5-hydroxytryptamine or 5-HT) is a 
well-conserved pathway originating in unicellular organisms around 3 billion years ago.
20
  
Its early appearance allowed its near ubiquitous use in life and eventually as a cell-to-cell 
signaling molecule along with its corresponding receptors.
21
  The first appearance of the 
G protein-coupled 5-HT receptor was more than 750 million years ago, demonstrating the 
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evolutionarily early use of 5-HT as a signaling molecule.
22
  In fact, there is strong 
evidence that the first 5-HT receptor was the basis for the biogenic amine receptor system 
in general.
22-23
  Given the molecules pervasive presence throughout both plant and animal 
life, genomic homologies in these signaling pathways can help inform about phylogenic 
relationships.  
The goal of the research presented here is to compliment current genomic 
investigations for Pleurobrachia bachei.
19, 24
  The use of multiple techniques for the 
analysis of the molecular makeup of an animal can establish congruence which imparts 
more certainty to claims of phylogenic placement.  Here, our results agree with genomic 
data suggesting the absence of many classical neurotransmitters including serotonin, 
acetylcholine, epinephrine, dopamine, norepinephrine, and histamine and the presence of 
glutamate and gamma-aminobutyric acid (GABA). 
 
6.2 Experimental 
6.2.1 Chemicals and Materials 
Standards and chemicals were obtained from Sigma-Aldrich (St. Louis, MO, 
USA) at the highest purity possible unless otherwise noted. Serotonin was purchased 
from Alfa Aeser (Ward Hill, MA, USA).  Water for all solutions and standards was 
obtained from an Elga PureLab Prima water filtration system (Woodridge, IL, USA) at 
purity of 18.2 MΩ.  
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6.2.2 Standards and Solutions 
Extraction media consisted of 49.5/49.5/1, methanol (LC-MS grade)/water/glacial 
acetic acid (99%) by volume.  Standards were weighed (1-2 mg) on a microbalance 
(Mettler Toledo; Columbus, OH, USA) and dissolved in extraction matrix for high 
concentration stock solutions.  These stocks were stored at -80°C until use for dilution to 
working concentrations. Citric acid (25 mM, pH 2.5) was prepared by dissolving 5.25 g 
citric acid in 1.0 L ultrapure water.    Borate buffer (50 mM, pH 9.25) for separations was 
prepared by dissolving 9.2 g of sodium borate with 3.0 g of boric acid in 1 L of ultrapure 
water.  Both the citric acid and borate buffers were filtered using a 0.22 µm vacuum filter 
and degassed by maintaining the vacuum for 20 min while stirring.  Artificial sea water 
(ASW) consisted of (mM) 460 NaCl, 10 KCl, 10 CaCl2, 22 MgCl2, 26, MgSO4, and 10 
HEPES (pH 7.7). 
 
6.2.3 Animal Collection and Species 
The species included in this work were Pleurobrachia bachei, Bolinopsis 
infundibulum, Bereo abyssicola, Polyorchis penicillatus and Soccoglossus.  Animals 
were collected from the coast of Friday Harbor in Washington State, USA by Leonid 
Moroz and his colleagues and shipped live to UIUC; all species identifications were 
performed by them.  One animal of each species were collected and shipped in October, 
2010 and additional 3 specimens of Pleurobrachia bachei collected March, 2012.    
Animals were shipped overnight in filtered sea water on wet ice.   
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6.2.4 Sample Preparation 
6.2.4.1 Dissection 
When received, the animals were kept in seawater at 0 – 10°C and used within 36 
hours of arrival.  Pleurobrachia bachei, Bolinopsis infundibulum, Polyorchis Penicillatus 
animals were individually placed in a petri dish filled with filtered sea water under a 10x 
stereoscope.  From the Pleurobrachia, tentacles, combs, tentacular sheaths, and stomach 
were individually removed as indicated in Fig. 6-3 using sharp dissection scissors.  From 
the Bolinopsis, the abhoral region, combs, and tissue surrounding the combs were 
removed.  From Polyorchis, the aurial, lobes, mouth were dissected.  Each dissected 
tissue was quickly dipped into ultrapure water immediately after dissection and prior to 
extraction to reduce contamination and salt from the filtered sea water. 
Bereo abyssicola was pharmacologically treated with 5-hydroxytryptophan (5-
HTP).  The whole animal was placed in a solution of artificial sea water at a 
concentration of 250 µM of 5-HTP for 60 min at 4°C.  Combs, mouth, and tissue 
surrounding combs were dissected and placed into a tube maintained at 4°C 
 
6.2.4.2 Tissue Extraction 
Extraction solution was added to each tissue at a volume approximately 2x the 
volume of tissue collected.  Each tissue sample was sonicated for 1-2 min for complete 
homogenization with extraction media.  Then, each sample was placed at 4°C for 90 min 
for extraction.  Afterwards, samples were centrifuged at 15,000 for 15 min and the 
supernatant removed and frozen at -80°C until analysis. 
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6.2.5 Analysis Methods 
6.2.5.1 Capillary Electrophoresis – Laser-Induced Native Fluorescence 
A laboratory-constructed CE-LINF system was used to analyze samples for 
indolamines and catecholamines.
25
  The CE separations were performed using a BGE of 
25 mM citric acid (pH 2.5, applied voltage +30 kV) or 50 mM borate (pH 9.5, applied 
voltage +21 kV).  BGE was filtered using a 0.2 µm surfactant-free, cellulose acetate 
syringe filter (Nalgene; Rochester, NY, USA) immediately prior to use.  Between each 
separation the capillary was conditioned for 5 min with 0.1 N NaOH and then rinsed for 
5 min with the BGE.  Approximately 10 nL of sample was hydrodynamically injection 
into the capillary. 
Limits of detection reported in Table 6-1 were defined as the concentration of 
analyte with a signal-to-noise ratio of 3 with the signal as the peak fluorescence intensity 
of the particular analyte peak and the noise the standard deviation of the background 
immediately preceding the peak. 
 
6.2.5.2 Capillary Electrophoresis – Mass Spectrometry 
CE-ESI-MS analysis was accomplished by using instrumentation previously 
reported by our group using either a Bruker Microtof or a Maxis (Bruker Daltonics; 
Billerica, MA, USA) for detection modes.
26-27
  Briefly, all separations were performed 
using 1% formic acid in water as the electrolyte and applied voltage of +30 kV.  The 
sheath liquid was 0.1% formic acid in 50/50 methanol/water.  Samples were 
hydrodynamically injected for a total volume of ~ 6 nL.  Mass spectra were collected and 
recorded at a rate of 2 Hz with calibration was performed using sodium formate clusters. 
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6.3 Results and Discussion 
The resolution of the relative placement of basal phyla is poor, partially because 
of the inability to study intermediate, extinct species and partially due to the lack 
molecular and genomic analysis of existing species in the basal phyla.  A comparative 
approach can be taken which studies morphological, cellular, and molecular features of 
species within these basal phyla, including the ctenophore.
28
  Several species of 
ctenophore, Pleurobrachia bachei, Bolinopsis infundibulum, Bereo abyssicola, were 
collected and analyzed to determine the presence of classical neurotransmitters as well as 
a cnidarian Polyorchis penicillatus and a control animal from bilateria, Soccoglossus.  
The focus of this work was on serotonin due to its wide spread use in life and previous 
genomic and transcriptomic studies conducted by our collaborators which showed an 
interesting absence of enzymes used for serotonin synthesis.  This result being significant 
enough that further confirmation was warrented to rule out errors in the genomic data or 
unidentified synthetic pathways.  Of course, approaches for indole measurements have 
been well-documented in prior chapters. 
The targeted areas indicated in Fig. 6-2 are nerve-rich tissues which would be the 
most probable areas for serotonin production as well as other neural signaling molecules.  
While extensive measurements for serotonin in Pleurobrachia revealed no detectable 
levels of 5-HT, the Cnidarian Polyorchis Penicillatus did, as well as our control species 
from Bilateria phyla, Soccoglossus, as is demonstrated by Fig. 6-3 and 6-4.  Fig. 6-3 
compares the wavelength-resolved electropherogram from a serotonin-rich tissue of 
Soccoglossus, Panel A, and the typical analysis of tissue from Pleurbrachia, Panel B.  
The presence of 5-HT in the two control species demonstrates the CE-LINF technique is 
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applicable for analysis of these systems, but if any 5-HT is present within Pleurobrachia 
it is below the instruments sensitivity 1 nM.  Without evidence from genomic or 
molecular analysis for the presence of a serotonergic system from Pleurobrachia bachei, 
Bolinopsis infundibulum, or Bereo abyssicola it is increasingly unlikely the phyla uses 
serotonin for signaling.  This is a surprising result given the widespread occurrence of 
serotonin throughout the Metazoa. 
While our primary goal was evaluation for serotonin, the opportunity was taken to 
determine if a number of other signaling compounds were present including dopamine, 
acetylcholine, GABA, and glutamate using CE-ESI-MS for detection.  As indicated in 
Table 6-1 tryptophan, tyrosine, serine, GABA, aspartate, glutamate were all present 
within Pleurobrachia bachei tissue, matching both migration times and monoisotopic 
mass.  Extracted chromatograms for the corresponding masses are provided in Fig. 6-5.  
As both GABA and glutamate signaling systems are also widespread throughout 
Metazoa, their presence is not surprising.
12
  
 
6.4 Conclusions 
Advances in molecular and genetic methods over the past decade have 
demonstrated prior misconceptions on relationships between taxa and the power of these 
new insights.  Bilateria have been extensively investigated, but more basal phyla have are 
still under analysis.  The lack of detectable serotonin in multiple species of Ctenophora is 
an interesting observation in the context of evolution of the nervous system.  However, 
while serotonin is well conserved it is only one of many signaling systems.  We have 
shown here a surprising lack of serotonin within these animals as well as no evidence of 
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many classical neurotransmitters found throughout life.  However, there are indications 
of GABA and glutamate.  
 
6.5 Future Directions 
Future studies into the nervous system of Ctenophora should focus on which 
signaling systems are present.  Now that GABA and glutamate have been identified 
within the Pleurobrachia bachei mechanistic studies can be conducted to further 
investigate their role in these early nervous systems.  Perhaps most intriguing is to 
determine which neurochemical signaling systems have taken over the roles of 5-HT in 
development, body plan formation and cell-cell signaling.  
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6.6 Tables and Figures  
 
Analyte CE-LINF CE-ESI-MS 
 Detection 
Limit 
(nM) 
Result in 
Pleurobrachia 
Detection 
Limit 
(nM) 
Result in  
Pleurobrachia-
Mass Match 
(mDa) 
Serotonin 1 ND NA -- 
Tryptophan 5 D <125 nM D-2.2 
Tyrosine 88 D <125 nM D-1.0 
Dopamine 36 ND <125 nM ND 
Norepinephrine 91 ND <125 nM ND 
Epinephrine 94 ND <125 nM ND 
Octopamine 10 ND <125 nM ND 
L-Dopa NA -- <125 nM ND 
5-Hydroxy 
Tryptophan 
NA -- <125 nM ND 
Tryptamine 2 ND <125 nM ND 
Indole 3 Acetic 
acid 
6 ND NA -- 
Indole butyric acid 13 ND NA -- 
Histamine NA -- <125 nM ND 
Acetocholine NA -- <125 nM ND 
Tyramine 25 ND <125 nM ND 
Serine NA -- <125 nM D-1.5 
Gaba NA -- <125 nM D-1.5 
Aspartate NA -- <125 nM D-1.6 
Glutamate NA -- <125 nM D-0.6 
  
 D    – Detected 
 ND – Detectable in standard, but not observed in any Ctenophore tissues 
 NA – Not detectable by the method 
 
Table 6-1  Summary of analyses of Pleurobrachia bachei combs for both CE-LINF 
and CE-ESI-MS methods.  Several combs were pooled from 2 animals. 
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Fig. 6-1 Classical representation of a progressive acquisition of a centralized nervous 
system, with ctenophores and cnidarians placement largely unresolved, but prior to 
Bilaterians. Reproduced from Galliot, B.; Quiquand, M.; Ghila, L.; de Rosa, R., et al., 
Origins of neurogenesis, a cnidarian view. 2009 Developmental Biology, 332 (1), 2-24. 
with permission.
29
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Fig. 6-2 Photograph of one of the Pleurobrachia bachei used during these measurements, 
with labels indicating the target tissue for analysis.  These areas were chosen as they are 
nerve rich tissues and are more likely contain neuroactive compounds. 
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Fig. 6-3 Representative wavelength-resolved electropherograms from soccogloassis 
(Panel A) and Pleurobrachia bachei (Panel B).  Soccogloasis was used as a control 
animal and serotonin was detectable in all tissues collected.  However, no serotonin was 
detectable in any animals or tissues collected for Pleurobrachia bachei. 
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Fig. 6-4 Single-channel electropherograms for the wavelength corresponding to the 
maximum fluorescence of serotonin ~335 nm.  Traces include analysis from all tissues 
collected from Pluerobrachia bachei and the standard containing serotonin.  This 
represents that even at detection limits of 1 nM serotonin was undetectable in any tissue 
for this species of Ctenophore.  
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Fig. 6-5 The extracted mass hr matograms for the detected compounds indicated in Table 1.  
(1) GABA, (2) serine e (3) tryptophan (4) glutamate (5) tyrosine (6) aspartate 
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Chapter 7 
 
Single Neuron Analysis from Drosophila Melanogaster 
 
Notes and Acknowledgements 
 The work presented within this chapter was completed in collaboration with Dr. 
Suzanne Neupert (a visiting scholar in the Sweedler group on a German Academic 
Exchange Service Fellowship) who performed the dissections of the single neurons from 
Drosophila melanogaster and Wolf Huetteroth who bred the flies.  This chapter is a part 
of a larger effort to combine a number of analytical techniques to evaluate neural circuits 
within defined phenotypes of Drosophila melanogaster.  Funding within the Sweedler 
group was from the National Institutes of Health through R01 NS031609 and P30 
DA018310. 
 
7.1 Introduction 
The goals of this chapter are two-fold, one more analytical and one more 
biological.  The analytical goals relate to the challenges of selecting, sampling and 
assaying well-defined neurons that are literally orders of magnitude smaller in volume 
than the Aplysia neurons and mammalian samples described in prior chapters.  The 
biological goals take advantage of the premier genomics model – the fruit fly – to 
understand the neurochemical perturbations caused by well-defined mutations. 
As described in Chapter 1, the nervous system regulates internal states along with 
monitoring and responding to the outside world using complex neuronal circuitry.  This 
complexity of neural configuration demands analysis on the single-cell level to 
interrogate cell-to-cell communication and cell-specific stimuli responses to understand 
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even the most basic of functions.  The size, volume, and trace levels of compounds of 
single cells presents significant challenges in measurements as reviewed by Lu et al.
1
  
However, chemical analysis is only as effective as the sampling method.  Isolation of 
individual cells from tissue has been accomplished using micropipettes and optical traps 
as well as hyphenated techniques
2
 to limit the perturbation to the delicate sample.  
Micropipettes allow for more control of cells or even single vesicles
3
 over the weaker 
forces involved in optical trapping, but physical manipulations can easily damage cells, 
potentially altering the chemical composition.  Optical traps do not require physical 
manipulation cells with implements, but damage can occur from absorption of photons 
used to create the trap.  Obtaining high-quality single cells from tissue is challenging, 
particularly when working with neurons which inherently respond to external stimuli. 
Developing new and improved techniques for sampling single-cells is critical to the 
investigations of cell-to-cell communication. 
Methods for single-cell analysis can be broadly categorized into separations and 
direct measurements.  Within separation based approaches capillary electrophoresis (CE) 
has been extensively used due to its compatibility with low-volume samples and 
ultrasensitive detection techniques for the analysis of a wide range of target analytes - 
from gaseous NO to large proteins.
4
  Single-cell applications of CE are the subject of 
several reviews demonstrating the significant contribution of CE analysis to single cell 
analysis.
1, 4-8
  In particular, laser-induced fluorescence (LIF) and electrochemical (EC) 
detection schemes are the widely used due to thier inherent sensitivities. 
Drosophila is a commonly used model system as it is genetic tractable and 
capable of higher-order functions even with a relatively simple brain.
9
  The genome of 
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Drosophila was one of the first sequenced and with little genetic redundancy genes can 
be linked to behavior and biochemical production.
9-10
  Specific neurotransmitters have 
been linked to behaviors and functions such as octopamine in aggression,
11
 dopamine in 
both olfactory memories
12
 and arousal,
13
 and tyramine for addition to cocaine.
14
  
Selectively perturbing molecular or cellular activities and determining changes in 
behavior, function, or chemical states is a powerful method for understanding the roles of 
specific neurons.  A number of molecular genetic strains have been developed to study 
neuronal activity in the Drosophila model, the one used in this work selectively controls 
neuronal endocytosis.
15
  While an excellent genetic model for studying the nervous 
system, practical challenges given is its small brain (~5 nL) and neurons (~5-15 µm) 
require particularly sensitive methods for analysis.
16-17
 
Drosophila with the shibire
ts1 
(shi
ts1
) or shibire
ts2 
(shi
ts2
) mutations are neurogenic 
phenotypes resulting in reversible, temperature-gated arrest of endocytosis as a result of a 
mutation in the structure of Dynamin, a protein required for endocytosis.
18-21
  While the 
structural abnormalities between these two mutants differ, both result in temperature-
gated endocytosis, disrupting synaptic activity by blocking synaptic recycling.  Above 
the threshold temperature of 30°C endocytosis arrests, below the threshold endocytosis 
occurs normally, providing a temporally-selective control of neuronal activity.  The 
shibire mutants are a well-established model for the investigation of neural 
mechanisms.
15, 22-23
  The effect of endocytosis/exocytosis arrest has been used to study 
development
24
 and phototransduction
25
 by selectively subjecting these flies to increased 
temperature pulses.  
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From an analytical perspective, we described the interrogation of ~10 µm 
individual neurons from Drosophila melanogaster using a novel sampling approach and 
genetic strains.  Serotonergic neurons were visualized by using genetic variants 
expressing GFP within the same neurons expressing the rate limiting enzyme, tryptophan 
hydroxylase (Trh), for serotonin synthesis.  Additionally, the shibire mutant was used to 
stabilize the cell during the dissection process by virtue of the temperature-gated 
inhibition of neurosecretory release.  While the shi
ts1
 and shi
ts2 
strains have been used for 
the interrogation of neural mechanisms, here we employ it as a method to prevent 
neurotransmitter release during cell isolation, thus allowing for a more accurate chemical 
inventory of individual neurons. 
 
7.2 Experimental  
7.2.1 Chemicals and Solutions 
The standards and chemicals, at the highest purity possible, were obtained from 
Sigma-Aldrich (St. Louis, MO, USA) unless otherwise noted. Serotonin was purchased 
from Alfa Aeser (Ward Hill, MA, USA).  Water for preparing the solutions and 
standards was obtained from an Elga PureLab Prima water filtration system (Elga LLC; 
Woodridge, IL, USA) at purity of 18.2 MΩ.  
Extraction solution consisted of 49.5/49.5/1, methanol (LC-MS 
grade)/water/glacial acetic acid (99%) by volume.  Standards were weighed (1-2 mg) on a 
microbalance (Mettler Toledo; Columbus, OH, USA) and dissolved in extraction matrix 
for high concentration stock solutions.  These stocks were stored at -80°C until use for 
dilution to working concentrations of.  Borate buffer (50 mM, pH 9.25) for separations 
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was prepared by dissolving 9.2 g of sodium borate with 3.0 grams of boric acid in 1 L of 
ultrapure water.  Both citric acid and borate buffers were filtered using a 0.22 µm vacuum 
filter and degassed by maintaining the vacuum for 20 min while stirring.  Dissection 
solution consisted of 0.9% saline solution. 
 
7.2.2 Capillary Electrophoresis – Laser-Induced Native Fluorescence Analysis 
A 150/50 µm ID/OD fused silica capillary (Polymicro Technologies; Phoenix, 
AZ, USA) was used as the separation column.  Approximately 20 nL of the sample was 
hydrodynamically injected into the capillary by lowering the outlet for 45 s.  Separations 
were performed in 50 mM borate buffer and potential of +21 kV applied.  The sheath-
flow liquid was 25 mM citric acid.  Peaks resulting from the analysis of single neurons 
were identified by comparison of both migration time and fluorescence emission to that 
of standards.  Several controls were analyzed to ensure peaks were derived from the 
single neuron shown in Fig. 7-2 - extraction solution, dissection solution, and material 
from surrounding tissue. 
 
7.2.3 Fly Stocks and Neuron Isolation 
Flies were bred by Wolf Huetteroth at the University of Massachusetts Medical 
School.  Briefly, w UAS-shi
ts1
/FM70-GFO;UAS-mCD8::GFP/CyO;(UAS-shi
ts1
) or (+)/+ 
were crossed with FM7/Y;UAS-mCD8::GFP/CyO;Trh-gal4/TM3 Sb and  wUAS-
shi
ts1
/wUAS-shi
ts1
;+/sp; wUAS-shi
ts1 
or (+)/TM6 B were crossed with FM7a/Y;UAS-
mCD8::GFP/UAS-mCD8::GFP;Trh-gal4/TM3 Sb.  The genetic strains created and used 
here are listed in Table 7-1.   
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The target neuron was dissected from the surrounding tissue under a fluorescence 
microscope (Zeiss V12 stereo Lumar; Jena, Germany).  Pulled glass capillaries which 
had been treated with poly-D-lysine were used to hydrodynamically obtain the cell 
without handling.  After settling and adhering to the side of the capillary a minimal 
volume (~100 nL) of extraction media was drawn into the capillary to cover the cell.  
Extraction from the single neuron occurred within the pulled capillary at 4°C until 
analysis by CE-LINF 90 min later.  
 
7.3 Results and Discussion 
As is the case within most animals, the serotonergic neurons in Drosophila are 
few and dispersed throughout the CNS, as can be seen in Fig. 7-1.  Even with the limited 
number of serotonergic neurons, the impact of the serotonergic system on CNS activity 
and organism behavior is profound.  Serotonin acts as both a neurotransmitter and 
neuromodulator, and is implicated in learning and memory, feeding, and movement 
within Drosophila.
26
  Understanding the metabolic pathways and regulation of serotonin 
within these neurons is important to gaining insight into its influence in these diverse 
functions and behaviors.   
Measurements were made using both GFP expressing strains of Drosophila and 
strains expressing both GFP and the temperature-sensitive, shi
ts1
 mutation.  Control 
measurements of dissection solution, extraction solution, and the extracellular fluid 
surrounding the neurons determined the signals that were a result of the individual 
neuron and those occurring from contamination from tissue surrounding the neuron, Fig. 
7-2.  While the dissection and extraction solutions did not present unexpected signals, the 
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extracellular fluid contained a number of bands with fluorescence emission in the 400-
600 nm range.  These bands are likely due to fluorescent compounds from the eye as the 
targeted neuron indicated in Fig. 7-1 is in close proximity to the eye which is highly 
pigmented.   
 
7.3.1 GFP Expressing Mutant 
Expression of GFP within the targeted neurons provides a guide for identification 
and dissection of a particular neuron from a large number of animals.  With the rate-
limiting enzyme for serotonin being expressed within these neurons, presence of 
serotonin is expected.  However, the extent of serotonin production is unknown.  Similar 
methods using GFP have been used to target specific neurons for peptidome studies.
16
  
Here, the serotonergic neurons are clearly visible with the target neuron indicated with an 
arrow at the perimeter of the brain in Fig. 7-1.  More than 50 individual neurons were 
analyzed using CE-LINF.  Tryptophan and tyrosine were detected routinely within these 
neurons, suggesting that the isolation and analysis were effective; unexpectedly, only 2 of 
these neurons contained detectable levels of serotonin.  An example electropherogram for 
both serotonin positive and serotonin negative results are given in Fig. 7-3A and B, 
respectively.   
 
7.3.2 Shibire Mutant 
We hypothesized that during the isolation of the neurons, the readily releasable 
pool of vesicles are released due to the mechanical manipulations of the cells.  Thus, we 
developed an approach to selectively inhibit vesicular release, in essence a form of 
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neuronal stabilization during the dissection and sampling process.  Often the limitations 
for single neuron analysis are rooted in obtaining a sample with minimal perturbation of 
its chemical contents.
27
  As neurons are inherently sensitive to chemical, electrical and 
mechanical stimuli, the potential for altering the chemical compliment during dissection 
is high.  The shi
ts1
 mutant allows for temporal control of neurosecretory activity.  Flies 
were allowed to develop normally to the adult stage of its life cycle, but an increase in 
temperature to 31°C immediately prior to and during dissection reduces vesicular release, 
stabilizing the neuronal content, allowing for improved detection of its vesicular content.  
Of the strains of the cross bred flies containing the shi
ts1
 mutation we found that only one 
strain had a higher success rate for detection of enhanced levels of tryptophan 
metabolites than the GFP only strain, mutant 4 from Table 7-1.   
Not only did this strain facilitate detection of serotonin in neurons for which the 
enzymes are expressed, the presence of tryptamine was confirmed along with an intense 
signal from an, as of yet, unidentified indole-like compound, Fig. 7-3C.  The unidentified 
signal has the same emission spectrum as tryptophan, but with a slightly longer migration 
time.  In addition to detecting previously undetected metabolites, the signal from 
serotonin and tryptophan were significantly larger in shi
ts1
 than the GFP only mutant, 
approximately four-fold higher in intensity for both analyts. 
 
7.4 Conclusions 
We have developed and validated several protocols that enable us to isolate 
selected cells (here labeled with GFP) and characterize them for their indoles and 
catechols.  Because the cells are about 10-fold smaller in diameter than the Aplysia 
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neurons, they contain 1000-fold less material.  With optimized sampling, we were still 
able to characterize selected metabolites in these cells.  The techniques developed in this 
work for the interrogation of single neurons from Drosophila melanogaster demonstrate 
a novel method for the determination of the neuronal contents.  Trace levels of serotonin, 
tryptophan, and tyrosine could be detected in the flies expressing only GFP.  The use of 
the shi
ts1
 mutant and a temperature controlled dissection process not only substantially 
increase the signal from serotonin but revealed new metabolites that were previously 
undetectable, presumably as a result of manual manipulation during the dissection 
process.   
In addition to the positive aspects of this study, the results also demonstrate an 
important aspect of single-cell measurement, the perturbation of the cell content caused 
during the dissection and sample handling.  Such factors need to be considered when 
interpreting results.  While many techniques are capable of detection at trace levels of 
selected compounds, validated sampling protocols are critical to preserving the complex 
chemical content of individual cells.  This work was one part of a larger set of analytical 
methods for the analysis of single neurons from Drosophila which included small-
molecule, metabolomics using CE-ESI-MS
28
 and peptidomics using MALDI. These 
complementary methods for interrogating individual cells can help create a more 
comprehensive analysis of the distribution of neuroactive compounds in the CNS at the 
cellular level. 
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7.5 Future Directions 
Only one specific neuronal subtype within the Drosophila brain has been 
investigated here.  Future work will validate these findings and focus on a larger 
coverage of neurons and neurotransmitters. Interrogation of neurons expressing other 
neurotransmitters is likely to identify other metabolites not previously measured.  
Universal measurement techniques such as CE-MS will provide a platform to discover 
other, possibly unidentified metabolites or intermediates.  Identifying the unknown 
compound detected with the shi
ts1
 mutant neuron should be accomplished using multiple, 
complimentary techniques.  Specifically, using CE-LINF as well as microscale mass 
spectrometry techniques would aid in this investigation. 
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7.6 Tables and Figures 
 
 
Mutant 1 FM7a/UAS-ShiTs1 ; GFP/Sp; TM6B/Trh-gal4 
Mutant 2 FM7a/UAS-ShiTs1 ; GFP/Sp; TM6B/UAS-ShiTs1 
Mutant 3 Shi/Y; GFP/+ ; Trh-gal4/TM6B 
Mutant 4 FM7a/ShiTs1 ; GFP/Sp; Trh-gal4/ShiTs1 
Mutant 5 Shi/Y; GFP/+ ; Trh-gal4/ShiTsi 
Mutant 6 FM7a/ShiTs1 ; GFP/+; Trh-gal4/TM6B 
Mutant 7 ShiTs1/Y; GFP/+; Trh-gal4/TM6B 
Mutant 8 Shi/Y; GFP/Sp; Trh-gal4/ShiTs1 
Mutant 9 Shi/Y; GFP/CyO; Trh-gal4/+ 
Mutant 10 ShiTs1/Y; GFP/CyO; Trh-gal4/ShiTs1 
Mutant 11 FM7a/ShiTs1 ; GFP/CyO; Trh-gal4/ShiTs1 
 
Table 7-1 – The crossbred Drosophila produced several genetic variants.  The strains 
detailed here were used for single-neuron isolation and were analyzed by CE-LINF for 
presence of indolamines and catecholamines.  
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Fig. 7-1   Fluorescence image of Drosophila brain with GFP co-expressed with the rate-
limiting enzyme for serotonin synthesis, Trh.  This genetic strain allows for serotonergic 
neurons to readily be identified for dissection under a fluorescence microscope.  The 
arrow indicates the targeted neuron, chosen because it is close to the edge of the brain 
which is more accessible. 
Isolated Neuron 
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Fig. 7-2  The ultratrace level of analytes within single neurons require elimination of any 
potential contaminates.  The fluids contacting the cell during the dissection process were 
analyzed individually to confidently assign signals.  (A) Extraction solution, (B) 
dissection solution, and (C) extracellular fluid from outside the dissected neuron. 
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Fig. 7-3  Electropherograms from individual neurons identified in Fig. 7-1, representing 
both (A) serotonin positive result and (B) serotonin negative result.   Identified analytes 
bands are: (1) serotonin, (2) tryptophan, (3) tyrosine, and * bands detected from 
extracellular fluid in Fig. 7-2.  Differences in migration times are a result of a difference 
in the length of capillary used; all other conditions were the same. 
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Fig. 7.4 – Continued on next page. 
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Fig. 7-4  Results of analysis of a single neuron from mutant 4 showing significant levels of (1) tryptamine, (2) serotonin, (3) 
tryptophan, (4) and an unidentified metabolite with the same fluorescence spectra as tryptophan.  Panel B demonstrates the level of 
analytes compared to a 1 µM standard.  Panel C shows confirmation of the analytes identification for both serotonin and tryptamine by 
comparison of normalized fluorescence spectra.  Time scale in panel B was aligned for peaks identified by fluorescence spectra.
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